Tablets
| ANTIBIOTICS | |||
| S. No. | Generic Name | Composition | |
| 1 | CLARITHROMYCIN TABLETS I.P 500 MG | Each film coated tablet contains: Clarithromycin i.p—500 mg Excipients–q.s Colour: Lake of quinoline yellow & titanium dioxide i.p | |
| 2 | CLARITHROMYCIN TABLETS I.P 250 MG | Each film coated tablet contains: Clarithromycin i.p—250 mg Excipients–q.s Colour: Lake of quinoline yellow & titanium dioxide i.p | |
| 3 | AZITHROMYCIN TABLETS I.P 250 MG | Each film coated tablet contains: Azithromycin i.p— 250mg Excipients–q.s Colour:- Lake of quinoline yellow & titanium dioxide i.p | |
| 4 | AZITHROMYCIN TABLETS I.P 500 MG | Each film coated tablet contains: Azithromycin i.p— 500mg Excipients–q.s Colour:- Lake of quinoline yellow & titanium dioxide i.p | |
| 5 | LINEZOLID TABLETS I.P 600 MG | Each film coated tablet contains: Linezolid i.p—600 mg Excipients–q.s Colour: Titanium dioxide i.p | |
| 6 | LINEZOLID SUSTAINED RELEASE TABLETS 1200 MG | Each film coated tablet contains: Linezolid i.p—1200 mg Excipients–q.s Colour: Titanium dioxide i.p | |
| 7 | LEVOFLOXACIN TABLETS I.P 500 MG | Each film coated tablet contains: Levofloxacin Hemihydrate i.p q. to Levofloxacin—500 mg Excipients–q.s Colour: Ferric oxide red usp-nf, ferric oxide yellow usp-nf & titanium dioxide i.p | |
| 8 | NITROFURANTOIN SUSTAINED RELEASE TABLETS 100 MG | Each uncoated sustained release tablet contains: Nitrofurantoin i.p—100 mg Excipienst:q.s | |
| 9 | NITROFURANTOIN SUSTAINED RELEASE TABLETS 100 MG | Each film coated sustained release tablet contains: Nitrofurantoin i.p—100 mg Excipients–q.s Colour: Ferric oxide red usp-nf & titanium dioxide ip | |
| 10 | OFLOXACIN TABLETS I.P 200 MG | Each film coated tablet contains: Ofloxacin i.p— 200mg Excipients–q.s Colour: Titanium dioxide ip | |
| 11 | OFLOXACIN TABLETS I.P 400 MG | Each film coated tablet contains: Ofloxacin i.p— 400mg Excipients–q.s Colour: Ferric oxide yellow usp-nf & Titanium dioxide ip | |
| 12 | OFLOXACIN & ORNIDAZOLE TABLETS I.P | Each film coated tablet contains: Ofloxacin i.p— 200mg Orindazole i.p–500 mg Excipients–q.s Colour: Titanium dioxide ip | |
| 13 | CEFUROXIME AXETIL & POTASSIUM CLAVULANATE TABLETS I.P | Each film coated tablet contains: Cefuroxime axetile i.p eq. to cefuroxijme—250 mg Potassium clavulanate ip (as potassium clavulanate diluted ip) eq.to clavulanic acid—125 mg Excipients–q.s Colour: Titanium dioxide ip | |
| 14 | FAROPENEM SODIUM TABLETS J.P 200 MG | Each film coated tablet contains: Faropenem sodium hydrate j.p eq. to faropenem—200 mg Excipients–q.s Colour: Ferric oxide (red) usp nf & titanium dioxide ip | |
| 15 | FAROPENEM SODIUM TABLETS J.P 300 MG | Each film coated tablet contains: Faropenem sodium hydrate j.p eq. to faropenem—300 mg Excipients–q.s Colour: Ferric oxide (red) usp nf & titanium dioxide ip | |
| 16 | CEFPROZIL TABLETS USP 500 MG | Each film coated tablet contains: Cefprozil usp eq. to anhydrous cefprozil—500 mg Excipients–q.s Colour: Titanium dioxide ip | |
| 17 | CEFPODOXIME PROXETIL DISPERSIBLE TABLETS 100 MG | Each uncoated dispersible tablet contains: Cefpodoxime Proxetile i.p eq. to Cefpodoxime—100 mg Excipients–q.s | |
| 18 | CEFPODOXIME PROXETIL DISPERSIBLE TABLETS 50 MG | Each uncoated dispersible tablet contains: Cefpodoxime Proxetile i.p eq. to Cefpodoxime—50 mg Excipients–q.s | |
| 19 | CEFPODOXIME PROXETIL & OFLOXACIN TABLETS | Each film coated tablet contains: Cefpodoxime Proxetile i.p eq. to Cefpodoxime—200 mg Ofloxacin i.p—200 mg Excipients–q.s Colour: lake of sunset yellow fcf | |
| 20 | CEFUROXIME AXETIL TABLETS I.P 500 MG | Each film coated tablet contains: Cefuroxime Axetile I.p eq. to cefuroxime— 500 mg Excipients-q.s Colour: Titanium dioxide i.p | |
| 21 | CEFUROXIME AXETIL TABLETS I.P 250 MG | Each film coated tablet contains: Cefuroxime Axetile I.p eq. to cefuroxime— 250 mg Excipients-q.s Colour: Titanium dioxide i.p | |
| 22 | CEFIXIME & LACTIC ACID BACILLUS DISPERSIBLE TABLETS 200 MG | Each uncoated dispersible tablet contains: Cefixime trihydrate i.p eq. to cefixime—200 mg Lactic acid bacillus— 60million spores Excipients–q.s | |
| 23 | CEFPODOXIME PROXETIL & POTASSIUM CLAVULANATE TABLETS | Each film coated tablet contains: Cefpodoxime Proxetile i.p eq. to cefpodoxime—200 mg Potassium clavulanate ip (as potassium clavulanate diluted ip) eq. to clavulanic acid–125mg Excipients–q.s Colour: Lake of sunset yellow fcf & tartrazine dioxide I.p | |
| 24 | CEFPODOXIME PROXETIL & POTASSIUM CLAVULANATE TABLETS | Each film coated tablet contains: Cefpodoxime Proxetile i.p eq. to cefpodoxime—100 mg Potassium clavulanate ip (as potassium clavulanate diluted ip) eq. to clavulanic acid-62.5mg Excipients–q.s Colour: Titanium Dioxide I.p | |
| 25 | CEFPODIXME PROXETIL TABLETS I.P 200 MG | Each film coated tablet contains: Cefpodoxime Proxetile i.p eq. to cefpodoxime—200mg Excipients–q.s Colour: Titanium Dioxide i.p | |
| 26 | CEFIXIME & POTASSIUM CLAVULANATE TABLETS | Each film coated tablet contains: Cefixime Trihydrate I.P eq. to Anhydrous Cefixime— 100 mg Potassium Clavulanate Diluted IP) eq. to Clavulanic Acid–62.5 mg Excipients–q.s Colour: Titanium Dioxide IP | |
| 27 | CEFIXIME & OFLOXACIN TABLETS | Each film coated tablet contains: Cefixime Trihydrate I.P eq. to Cefixime—200 mg Ofloxacin I.P—200 mg Excipients–q.s Colour: Lake of sunset yellow fcf & titanium dioxide ip | |
| 28 | CEFIXIME DISPERSIBLE TABLETS IP | Each uncoated dispersible tablet contains: Cefixime Trihydrate I.P eq. to Cefixime—100 mg Excipients–q.s | |
| 29 | CEFIXIME DISPERSIBLE TABLETS IP | Each uncoated dispersible tablet contains: Cefixime Trihydrate I.P eq. to Cefixime—400 mg Excipients–q.s | |
| 30 | CEFIXIME TABLETS I.P 200 MG | Each Film coated tablet contains: Cefixime Trihydrate I.P eq. to Cefixime—200 mg Excipients–q.s Colour: Titanium dioxide ip | |
| 31 | AMOXYCILLIN & POTASSIUM CLAVULANATE TABLTS IP | Each film coated tablet contains: Amoxycillin Trihydrate ip eq. to amoxycillin —200 mg Potassium clavulanate ip (as potassium clavulanate diluted ip) eq. to clavulanic acid—28.5 mg Excipients–q.s Colour: Titanium Dioxide ip | |
| 32 | AMOXYCILLIN & POTASSIUM CLAVULANATE TABLTS IP | Each film coated tablet contains: Amoxycillin Trihydrate ip eq. to amoxycillin —500 mg Potassium clavulanate ip (as potassium clavulanate diluted ip) eq. to clavulanic acid—125 mg Excipients–q.s Colour: Titanium Dioxide ip | |
| 33 | AMOXYCILLIN & POTASSIUM CLAVULANATE TABLTS IP | Each film coated tablet contains: Amoxycillin Trihydrate ip eq. to amoxycillin —875 mg Potassium clavulanate ip (as potassium clavulanate diluted ip) eq. to clavulanic acid—125 mg Excipients–q.s Colour: Titanium Dioxide ip | |
| 34 | CEFPODOXIME PROXETIL DISPERSIBLE TABLETS | Each uncoated dispersible tablet contains: Cefpodoxime Proxetil i.p equivalent to cefpodoxime– 200 mg Excipients–q.s | |
| 35 | CEFPODOXIME PROXETIL & POTASSIUM CLAVULANATE TABLETS | Each film coated tablet contains: Cefpodoxime Proxetile i.p equivalent to cefpodoxime– 200 gm Potassium Clavulanated Diluted i.p eq. to clavulanic acid–125 mg Excipients –q.s Colour: Approved colour used | |
| 36 | AMOXYCILLIN & POTASSIUM CLAVULANATE TABLTS IP | Each film coated tablet contains: Amoxycillin Trihydrate i.p eq. to Amoxycillin— 250 mg Potassium Clavulanate Diluted i.p eq. to Clavulanic Acid– 125 mg Excipients–q.s Colour: Approved colour used | |
| 37 | AMOXYCILLIN, POTASSIUM CLAVULANATE & LACTIC ACID BACILLUS TABLETS | Each film coated tablet contains: Amoxycillin Trihydrate i.p eq. to Amoxycillin— 500 mg Potassium Clavulanate Diluted i.p eq. to Clavulanic Acid– 125 mg Lactic Acid Bacillus— 60 million spores Excipients–q.s Colour: Approved colour used | |
| 38 | CEFIXIME TRIHYDRATE & POTASSIUM CLAVULANATE TABLETS | Each film coated tablet contains: Cefixime Trihydrate i.p eq. to anhydrous cefixime— 200 mg Potassium Clavulanate Diluted i.p eq. to clavulanic acid–125 mg Excipients : q.s Colour: Approved colour used | |
| 39 | AZITHROMYCIN TABLETS I.P 500 MG | Each film coated tablet contains: Azithromycin (As Dihydrate) i.p–500 mg Excipients—q.s Colour: Approved Colours Used | |
| 40 | RIFAXIMIN TABLETS 400 MG | Each film coated tablet contains: Rifaximin b.p–400 mg Excipients–q.s Colour:- Approved colour used | |
| 41 | LINEZOLID TABLETS I.P 600 MG | Each uncaoted tablet contains: Linezolid i.p— 600 mg Excipients–q.s | |
| 42 | RIFAXIMIN TABLETS 200 MG | Each film coated tablet contains: Rifaximin b.p–200mg Excipients q.s Colour: Approved colours used | |
| 43 | NORFLOXACIN & TINIDAZOLE TABLETS | Each film coated tablet contains: Norfloxacin I.P—400 mg Tinidazole I.P—600 mg Excipients—q.s Colour: Approved colour used. | |
| 44 | FAROPENEM GASTRO RESISTANT TABLETS 300 MG | Each Enteric Coated Tablet Contains: Faropenem Sodium Hydrate J.P—300 mg Excipients: Q.s Colour : Approved Colour Used | |
| 45 | FAROPENEM SODIUM EXTENDED RELEASE TABLETS 300 MG | Each Film Coated Extended Release Tablet Contains: Faropenem Sodium Hydrate J.P—300 mg Excipients: Q.s Colour : Approved Colour Used | |
| 46 | AMOXYCILLIN AND POTASSIUM CLAVULANATE TABLETS USP | Each film coated tablet contains: Amoxycillin Trihydrate USP eq. to Amoxycillin— 875 mg Potassium Clavulanate USP (as potassium clavulanate diluted USP) eq. to Clavulanic Acid— 125 mg Excipients: q.s Colour: Approved Colour Used. | |
| 47 | 
| Each film coated tablet contains: Amoxicillin USP (as trihydrate) eq. to Amoxicillin—500 mg Diluted Potassium Clavulanate BP eq. to Clavulanic Acid—125 mg Excipients—q.s Colour: Approved colour used. | |
| 48 | CEFIXIME TABLET USP | Each film coated tablet contains: Cefixime USP (as trihydrate) eq. to Anhydrous Cefixime—200 mg Excipients—q.s Colour: Approved colour used. | |
| 49 | NORFLOXACIN TABLETS IP | Each un coated tablet contains: Norfloxacin—400 mg Excipients—q.s Colour: Approved colour used. | |
| 50 | RIFAXIMIN TABLETS 550 MG | Each film coated tablet contains : Rifaximin B.P. 550 mg Excipients q.s. Colour : Approved colour used | |
| 51 | NORFLOXACIN TABLETS IP | Each un coated tablet contains: Norfloxacin—400 mg Excipients—q.s Colour: Approved colour used. | |
| 52 | RIFAXIMIN TABLETS 550 MG | Each film coated tablet contains: Rifaximin B.P—550 mg Excipients—q.s Colour: Approved colour used. | |
| 53 | RIFAXIMIN TABLETS 200 MG | Each film coated tablet contains: Rifaximin B.P—200 mg Excipients—q.s Colour: Approved colour used. | |
| 54 | OFLOXACIN TABLETS USP 200 MG | Each film coated tablet contains: Ofloxacin USP—200 mg Excipients–q.s | |
| 55 | AMOXYCILLIN & POTASSIUM CLAVULANATE TABLTS IP | Each film coated tablet contains: Amoxycillin Trihydrate I.P eq. to Amoxycillin—250 mg Potassium Clavulanate Diluted I.P eq. to Clavulanic Acid—125 mg Excipients–q.s Colour: Approved colour used. | |
| 56 | LINEZOLID SUSTAINED RELEASE TABLETS 1200 MG | Each film coated sustained release tablet contains: Linezolid I.P—1200 mg Excipients—q.s Colour: Approved colour used | |
| 57 | LINEZOLID TABLETS I.P 600 MG | Each film coated tablet contains: Linezolid I.P—600 mg Excipients–q.s Colour:Approved colour used. | |
| 58 | CEFIXIME TABLETS I.P 200 MG | Each film coated tablet contains: Cefixime Trihydrate I.P eq. to Cefixime—200 mg Excipients—q.s Colour: Approved colour used | |
| 59 | AMOXYCILLIN & POTASSIUM CLAVULANATE TABLTS IP | Each film coated tablet contains: Amoxycillin Trihydrate Ip eq. to Amoxicillin—500 mg Potassium clavulanate diluted IP eq. to Clavulanic acid—125 mg Excipients—q.s Colour: Approved colour used. | |
| 60 | FAROPENEM SODIUM & POTASSIUM CLAVULANATE TABLETS | Each film coated tablets contains: Faropenem Sodium Hydrate JP eq. to Faropenem—200 mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid—125 mg Excipients—q.s Colour: Approved colour used. | |
| 61 | AMOXYCILLIN & POTASSIUM CLAVULANATE DISPERSIBLE TABLTS | Each unbcoated tablet contains: Amoxycillin Trihydrate IP eq. to Amoxycillin—400 mg Potassium clavulanate Diluted IP eq. to Clavulanic acid—57 mg Excipients–q.s Colour: Approved colour used. | |
| 62 | OFLOXACIN & ORNIDAZOLE TABLETS I.P | Each film coated tablet contains: Ofloxacin I.P—200 mg Ornidazole I.P—500 mg Excipients—q.s Colour: Approved colour used. | |
| 63 | MINOCYCLINE HYDROCHLORIDE TABLETS USP 100 MG | Each film coated tablet contains: Minocycline Hydrochloride U.S.P. eq. to Minocycline—100 mg Excipients—q.s Colour: Approved colour used. | |
| 64 | AMOXYCILLIN AND POTASSIUM CLAVULANATE & LACTIC ACID BACILLUS TABLETS | Each film coated tablet contains: Amoxycillin Trihydrate IP eq. to Amoxycillin—500 mg Potassium Clavulanate Diluted IP eq to Clavulanic Acid—125 mg Lactic Acid Bacillus—60 Million Spores Excipients—q.s Colour: Approved colour used. | |
| 65 | CEFPODOXIME PROXETILE & OFLOXACIN TABLETS | Each film coated tablet contains: Cefpodoxime Proxetile IP eq. to Anhydrous Cefpodoxime—200 mg Ofloxacin IP—200 mg Excipients—q.s Colour: Approved colour used. | |
| 66 | CEFIXIME DISPERSIBLE TABLETS IP | Each uncoated dispersible tablet contains: Cefixime Trihydrate IP qe. To Anhydrous Cefixime—50 mg Excipients—q.s In a flavoured base—q.s Colour: Approved colour used. | |
| 67 | CEFIXIME DISPERSIBLE TABLETS IP | Each uncoated dispersible tablet contains: Cefixime Trihydrate IP qe. To Anhydrous Cefixime—100 mg Excipients—q.s In a flavoured base—q.s Colour: Approved colour used. | |
| 68 | CEFPODOXIME PROXETILE DISPERSIBLE TABLETS | Each uncoated dispersible tabalets contains: Cefpodoxime Proxetile IP eq. to Anhydrous Cefpodoxime—50 mg Excipients—q.s In a flavoured base Colour: Approved colour used. | |
| 69 | CEFPODOXIME PROXETILE DISPERSIBLE TABLETS | Each uncoated dispersible tabalets contains: Cefpodoxime Proxetile IP eq. to Anhydrous Cefpodoxime—100 mg Excipients—q.s In a flavoured base Colour: Approved colour used. | |
| 70 | LEVOFLOXACIN TABLETS I.P 500 MG | Each film coated tablet contains: Levofloxacin Hemihydrate i.p q. to Levofloxacin—500 mg Excipients–q.s Colour: Approved colour used. | |
| 71 | AMOXYCILLIN AND POTASSIUM CLAVULANATE DISPERSIBLE TABLET B.P | Each uncoated dispersible tablet contains: Amoxycillin Trihydrate IP eq. to Amoxycillin—200 mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid—28.5 mg Excipients—q.s | |
| 72 | AMOXYCILLIN AND POTASSIUM CLAVULANATE DISPERSIBLE TABLET B.P | Each uncoated dispersible tablet contains: Amoxycillin Trihydrate IP eq. to Amoxycillin—200 mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid—28.5 mg Excipients—q.s | |
| 73 | TRIMETHOPRIM & SULFAMETHOXAZOLE TABLETS IP | Each uncoated tablet contains: Trimethoprim IP—160 mg Sulfamethoxazole IP—800 mg Excipients—q.s | |
| 74 | CEFUROXIME & POTASSIUM CLAVULANATE TABLETS | Each film coated tablet contains: Cefuroxime Axetile IP eq. to Cefuroxime—500 mg Potassium Clavulanate Diluted IP eq. to Clavulanic acid—125 mg Excipients–q.s Colour: Approved colour used. | |
| ANALGESIC, ANTIPYRETIC & ANTI-INFLAMATORY | |||
| S. No. | Generic Name | Composition | |
| 1 | TRYPSIN-CHYMOTRYPSIN WITH ACECLOFENAC & PARACETAMOL TABLETS | Each film coated tablet contains: Aceclofenac i.p— 100 mg Paracetamol i.p—325 mg 50,000 armour units of emzymatic actitvity (supplied by a purified concentrate which has specific trypsin & chymotrypsin acitivity in a ratio of approximately six to one) (As eneteric coated granuels) Excipients–q.s Colour: Lake of quinoline yellow & titanium dioxide i.p Warning: Overages of paracetamol has the potential for server liver injury and allergic reactions (e.g. swelling of the face, moluth and thraot, difficulty in breathing, itching or rash). | |
| 2 | ACECLOFENAC, PARACETAMOL & SERRATIOPEPTIDASE TABLETS (100 MG+ 325 MG+ 15 MG) | Each film coated tablet contains: Aceclofenac i.p—100 mg Paracetamol i.p— 325 mg Serratiopeptidase i.p—15 mg (eq. to 20000 enzyme unit.) Excipients:q.s Colour: Lake of brilliant blue fcf & titanium dioxide i.p Warning: Overdose of paracetamol has the potential for severe liver injury and allergic reactions (e.g. swelling of the face, mouth and throat , difficulty in breathing, itching or rash) | |
| 3 | ACECLOFENAC, PARACETAMOL & SERRATIOPEPTIDASE TABLETS (100 MG+ 325 MG+ 10 MG) | Each film coated tablet contains: Aceclofenac i.p— 100 mg Paracetamol i.p—325 mg Serratiopeptidase i.p—10 mg (eq. to 20000 enzymatic unit) Excipients–q.s Colour: Lake of brilliant blue fcf & titanium Warning: Overdosse of paracetaml has the potential for severe liver injury and allergic reaction (e.g. swelling of the face,mouth and throat , difficulty in breathing, itching or rash) | |
| 4 | NIMESULIDE TABLETS 100 MG | Each uncoated tablet contains: Nimesulide b.p—100 mg Excipients–q.s Warning–Use of nimesulide should ordinarily be restricted to 10 days. If longer clinical us eis warranted,liver function test should be assessed periodically. | |
| 5 | NIMESULIDE & PARACETAMOL TABLETS | Each uncoated tablet contains: Nimesulide b.p—100 mg Paracetamol i.p–325 mg Excipients–q.s Colour: Tartrazine Warning: Overdose of paracetamol has the potential for severe liver injury and allergic reactions (e.g. swelling of the face, mouth and throat, difficulty in breathing, itching or rash). | |
| 6 | PARACETAMOL & CAFFEINE TABLETS I.P | Each uncoated tablets contains: Paracetamol i.p—500 mg Caffeine anhydrous i.p—50 mg Excipients–q.s Warning: Overdose of paracetamol has the potential for severe liver injury and allergic reactions (e.g. swelling of the face, mouth and throat, difficulty in breathing, itching or rash). | |
| 7 | PARACETAMOL TABLETS I.P 650 MG | Each uncoated tablet contains: Paracetamol i.p—650 mg Excipients–q.s Warning: Overdose of paracetamol has the potential for severe liver injury and allergic reactions (e.g. swelling of the face, mouth and throat, difficulty in breathing, itching or rash). | |
| 8 | PARACETAMOL TABLETS I.P 500 MG | Each uncoated tablet contains: Paracetamol i.p—500 mg Excipients–q.s Warning: Overdose of paracetamol has the potential for severe liver injury and allergic reactions (e.g. swelling of the face, mouth and throat, difficulty in breathing, itching or rash). | |
| 9 | ETORICOXIB TABLETS I.P 60 MG | Each film coated tablet contains: Etoricoxib i.p—60 mg Excipients—q.s Colour: Lake of brilliant blue fcf, quinoline yellow, ferric oxide black usp-nf & titanium dioxide i.p | |
| 10 | ETORICOXIB TABLETS I.P 90 MG | Each film coated tablet contains: Etoricoxib i.p—90 mg Excipients—q.s Colour: Lake of sunset yellow & titanium dioxide i.p | |
| 11 | ETORICOXIB TABLETS I.P120 MG | Each film coated tablet contains: Etoricoxib i.p—120 mg Excipients—q.s Colour: Ferric oxide red usp-nf & titanium dioxide i.p | |
| 12 | TRYPSIN, BROMELAIN & RUTOSIDE TRIHYDRATE TABLETS | Eachc gastro-resistant tablet contains: Trysin b.p– 48 mg Bromelain–90 mg Rutoside Trihydrate b.p–100 mg Excipients–q.s | |
| 13 | DICLOFENAC POTASSIUM & SERRATIOPEPTIDASE TABLETS | Eachfilm coated tablet contains: Diclofenac Potassium b.p—50 mg Serratiopeptidase i.p— 10 mg (Eq. to 20,000 Enzyme Unit) (As enteric coated granuels) Excipients—q.s Colour: Approved Colour Used | |
| 14 | THIOCOLCHICOSIDE & ACECLOFENAC TABLETS | Each film coated tablet contains: Aceclofenac i.p— 100 mg Thiocolchicoside i.p—4 mg Excipients–q.s Colour: Approv ed colour used | |
| 15 | PARACETAMOL & ORPHENADRINE CITRATE TABLETS | Each uncoated tablet contains: Orphenadrine Citrate—345 mg Paracetamol—450 mg Excipients:q.s Colours: Approved colours used | |
| 16 | SERRATIOPEPTIDASE TABLETS I.P | Each film coated tabletg contains: Serratiopeptidase—5mg (eq. to 10,000 units of enzymatic activity) Excipienst—q.s Colour: Approved colour used. | |
| 17 | THIOCOLCHICOSIDE & KETOPROFEN TABLETS | Each film coated tablet contains: Thiocolchicoside IP—4 mg Ketoprofen IP—50 mg Excipients—q.s Colour: Approved colour used. | |
| 18 | TRAMADOL & PARACETAMOL TABLETS | Each film coated tablet contains: Tramadol Hydrochloride IP—37.5 mg Paracetamol IP—325 mg Excipients–q.s Colour: Approved colour used. | |
| 19 | TRAMADOL HCL SUSTAINED RELEASE TABLETS IP | Each sustained release tablet contains: Tramadol HCL IP—100 mg Excipients–q.s Colour: Approved colour used. | |
| 20 | TRAMADOL HYDROCHLORIDE 50 MG TABLETS | Each sustained release tablet contains: Tramadol Hydrochloride IP—50 mg Excipients–q.s Colour: Approved colour used. | |
| 21 | TAPENTADOL HYDROCHLORIDE TABLET 100 MG EXTENDED RELEASE | Each film coated extended release tablet contains: Tapentadol Hydrochloride IP eq. to Tapentadol—100 mg Excipients–q.s Colour: Approved colour used. | |
| 22 | TRAMADOL HYDROCHLORIDE WITH PARACETAMOL IP TABLETS | Each film coated tablet contains: Tramadol Hydrochloride IP—37.5 mg Paracetamol IP—650 mg Excipients–q.s Colour: Approved colour used. | |
| 23 | TAPENTADOL HYDROCHLORIDE EXTENDED RELEASE TABLETS | Each film coated extended release tablet contains: Tapentadol Hydrochloride IP eq. to Tramadol—200 mg Excipients–q.s Colour: Approved colour used. | |
| 24 | TAPENTADOL HYDROCHLORIDE 100 MG TABLETS | Each film coated ablet contains: Tapentadol Hydrochloride—100 mg Excipients–q.s Colour: Approved colour used. | |
| 25 | TAPENTADOL HYDROCHLORIDE TABLETS 50 mg EXTENDED RELEASE | Each film coated extended release tablet contains: Tapentadol Hydrochloride IP eq. to Tapentadol —50 mg Excipients–q.s Colour: Approved colour used. | |
| 26 | TRAMADOL HYDROCHLORIDE EXTENDED RELEASE TABLET USP | Each film coated ablet contains: Tramadol Hydrochloride IP —300 mg Excipients–q.s Colour: Approved colour used. | |
| 27 | TRAMADOL HYDROCHLORIDE TABLET USP 100 MG (FOR EXPORT ONLY) | Each film coated ablet contains: Tramadol Hydrochloride USP—100 mg Excipients–q.s Colour: Approved colour used. | |
| 28 | TRAMADOL HYDROCHLORIDE TABLETS USP 50 MG | Each film coated tablet contains: Tramadol Hydrochloride USP—50 mg Excipients—q.s Colour: Approved colour used. | |
| 29 | TRAMADOL HYDROCHLORIDE & ACETAMIOPHEN TABLETS USP | Each film coated tablet contains: Acetamiophen USP—325 mg Tramadol HCL USP—37.5 mg Excipients—q.s Colour: Approved colour used. | |
| 30 | TRAMADOL HYDROCHLORIDE TABLETS USP | Each film coated tablet contains: Tapentadol Hydrochloride IP eq. to Tapentadol—75 mg Excipients—q.s Colour: Approved colour used. | |
| 31 | TAPENTADOL TABLETS 50 MG | Each film coated tablet contains: Tapentadol Hydrochloride IP eq. to Tapentadol—50 mg Excipients—q.s Colour: Approved colour used. | |
| 32 | MELOXICAM TABLET BP 15 MG | Each film coated tablet contains: Meloxicam BP—15mg Excipients—q.s Colour: Titanium dioxide bp sunset yellow & erythrosine lake. | |
| 33 | DICLOFENAC POTASSIUM PARACETAMOL & SERRATIOPEPTIDASE TABLETS | Each film coated tablet contains: Diclofenac Potassium BP—50 mg Paracetamol IP—325 mg Serratiopeptidase IP—15 mg (eq. to 30,000 units of enzymatic acitvity) Excipients—q.s Colour: Approved colour used. | |
| 34 | THIOCOLCHICOSIDE & ACECLOFENAC TABLETS | Each film coated tablet contains: Aceclofenac I.P—100 mg Thiocolchicoside I.P—8 mg Excipients—q.s Colour: Approved colour used | |
| 35 | IBUPROFEN & ACETAMINOPHEN TABLETS | Each uncoated tablet contains: Ibuprofen USP—400 mg Acetaminophen USP—325 mg Excipients—q.s | |
| 36 | 
| Each film coated tablet contains: Each film coated tablet contains: Ibuprofen BP—400 mg Excipients—q.s Approved colour used. | |
| 37 | NAPROXEN TABLETS IP | Each film coated tablet contains: Naproxen IP—250 mg Excipients—q.s Colour: Approved colour used. | |
| 38 | MELOXICAM TABLET BP 7.5 MG | Each film coated tablet contains: Meloxicam BP—7.5 mg Excipients—q.s Colour: Approved colour used | |
| 39 | NAPROXEN SODIUM & DOMPERIDONE TABLETS | Each film coated tablet contains: Naproxen Sodium USP eq. to Naproxen—250 mg Domperidone Maleate IP eq. to Domperidone—10 mg Excipients—q.s Colour: Approved colour used. | |
| 40 | DICLOFENAC POTASSIUM & PARACETAMOL TABLET | Each film coated tablet contains: Diclofenac Potassium BP—50 mg Paracetamol BP—325 mg Excipients—q.s Colour : Approved colour used. | |
| 41 | MELOXICAM TABLETS B.P 7.5 MG | Each film coated tablet contains: Meloxicam BP—7.5 mg Excipients—q.s Colour: Approved colour used | |
| 42 | KETOROLAC TROMETHAMINE DISPERSIBLE TABLETS 10 MG | Each uncoated dispersible tablet contains: Ketoprolac Tromethamine IP—10 mg Excipients—q.s Colour: Approved colour used. | |
| 43 | MELOXICAM, PARACETAMOL,DOMPERIDONE & CAFFEINE TABLETS | Each film coated tablet contains: Meloxicam BP—20 mg Paracetamol BP—325 mg Domperidone BP—10 mg Caffeine (Anhydrous) BP—80 mg Colour: Approved colour used. | |
| 44 | 
| Each uncoated tablet contains: Paracetamol BP—325 mg Diclofenac Potassium BP—50 mg Excipients—q.s | |
| 46 | ACECLOFENAC SUSTAINED RELEASE TABLETS | Each film coated sustained-release tablet contains: Aceclofenac I.P—200 mg Excipients—q.s Colour: Approved colour used. | |
| 47 | ACECLOFENAC SUSTAINED RELEASE TABLETS 200MG | Each uncoated sustained release tablet contains: Aceclofenac I.P—200mg Excipients—q.s | |
| 48 | SULFASALAZINE GASTRO-RESISTANT TABLETS I.P 1000 MG | Each enteric coated tablet contains: Sulfasalazine I.P—1000 mg Excipients—q.s Colour: Approved colour used. | |
| 49 | NAPROXEN 250 MG & DOMPERIDONE 10 MG TABLETS | Each film coated tablet contains: Naproxen Sodium USP eq. to Naproxen—250 mg Domperidone Maleate IP eq. to Domperidone—10 mg Excipients—q.s Colour: Approved colour used. | |
| 50 | ACECLOFENAC & DROTAVERINE HYDROCHLORIDE TABLETS IP | Each film coated tablet contains: Aceclofenac IP—100 mg Drotaverine Hydrochloride IP—80 mg Excipients—q.s Colour: Approved colour used. | |
| 51 | SULFASALAZINE GASTRO-RESISTANT TABLETS I.P 500 MG | Each eneteric coated tablet contains: Sulfasalazine IP—500 mg Excipients—q.s Colour: Approved colour used. | |
| 52 | SULFASALAZINE GASTRO-RESISTANT TABLETS IP | Each eneteric coated tablet contains: Sulfasalazine IP—500 mg Excipients—q.s Colour: Approved colour used. | |
| 53 | MESALAMINE PROLONGED RELEASE TABLETS I.P. 1.2 GM | Each film coated prolonged release tablet contains: Mesalazine IP—1.2 gm Excipients—q.s Colour: Approved colour used. | |
| 54 | NAPROXEN 250 MG & DOMPERIDONE 10 MG TABLETS | Each film coated tablet contains: Naproxen Sodium USP eq. to Naproxen—250 mg Domperidone Maleate IP eq. to Domperidone—10 mg Excipients—q.s Colour: Approved colour used. | |
| 55 | NAPROXEN TABLETS IP 250 MG | Each film coated tablet contains: Naproxen IP—250 mg Excipients—q.s Colour: Approved colour used. | |
| 56 | MESALAZINE PROLONGED RELEASE TABLETS IP 800 MG | Each uncoated prolonged -release tablet contains: Mesalazine IP—500 mg Excipients—q.s | |
| 57 | MESALAZINE DELAYED RELEASE TABLETS IP 800 MG | Each uncoated delayed -release tablet contains: Mesalazine IP—800 mg Excipients—q.s | |
| 58 | MELOXICAM 7.5 MG TABLETS BP | Each uncoated tablet contains: Meloxicam IP—7.5 mg Excipients–q.s | |
| 59 | ACECLOFENAC & PARACETAMOL TABLETS | Each film coated tablet contains: Aceclofenac i.p— 100 mg Paracetamol i.p—325 mg Excipients–q.s Colour: Lake of sunset yellow fcf, tartrazine & titanium Warning: Overdosse of paracetaml has the potential for severe liver injury and allergic reactions (e.g. swelling of the face,mouth and throat, difficulty in breathing, itching or rash). | |
| 60 | ACECLOFENAC & PARACETAMOL TABLETS | Each film coated tablet contains: Aceclofenac BP—100 mg Paracetamol BP—500 mg Excipients—q.s Colour: Approved colour used. | |
| 61 | TAPENTADOL HYDROCHLORIDE EXTENDED RELEASE TABLETS | Each film coated extended-release tablet contains: Tapentadol Hydrochloride IP eq. to Tapentadol—100 mg Excipients—q.s Colour: Approved colour used. | |
| 62 | PARACETAMOL & NIMESULIDE TABLETS | Each uncoated tablet contains: Paracetamol IP—325 mg Nimesulide BP—100 mg Excipients—q.s | |
| ANTICOLD | ||
| S. No. | Generic Name | Composition |
| 1 | LEVOCETIRIZINE DIHYDROCHLORIDE, AMBROXOL HCL, PARACETAMOL, PHENYLEPHRINE HCL & CAFFEINE TABLETS | Each film coated tablet contains:
Levocetirizine Dihydrochloride I.P—5 mg Ambroxol HCL I.P—30 mg Paracetamol I.p—325 mg Phenylphirine hcl I.P—10 mg Caffeine Anhydrous I.P—25 mg Excipients—q.s Colour: Approved colour used |
| 2 | PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, CAFFEINE & DIPHENYDRAMINE HCL TABLETS | Each uncoated tablet contains:
Paracetamol I.P—500 mg Phenylephrine Hydrochloride I.P—5 mg Diphenhydramine Hydrochloride I.P—25 mg Caffeine (Anhydrous) I.P—30 mg Excipients—q.s Colour: Approved colour used. |
| 3 | NIMESULIDE, CETIRIZINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE & CAFFEINE TAB
| Each uncoated tablet contains:
Nimesulide BP—100 mg Cetiriizine HCL BP—10 mg Caffeine (as anhydrous) BP—15 mg Chlorpgeniramine Maleate BP—4 mg Excipients—q.s |
| ANTIDIABETIC | |||
| S. No. | Generic Name | Composition | |
| 1 | GLIMEPRIDE (1MG) , PIOGLITAZONE & SUSTAINED-RELEASE METFORMIN HYDROCHLORIDE TABLETS | Each film coated bi-layered tablet contains: Glimepiride i.p—1 mg Pioglitazone hydrochloride i.p eq. to pioglitazone—15 mg Metformin Hydrochloride i.p—500 mg (As sustained-release form) Excipients–q.s Colour: Brilliant Blue FCF | |
| 2 | GLIMEPRIDE (2 MG) , PIOGLITAZONE & SUSTAINED-RELEASE METFORMIN HYDROCHLORIDE TABLETS | Each film coated bi-layered tablet contains: Glimepiride i.p—2 mg Pioglitazone hydrochloride i.p eq. to pioglitazone—15 mg Metformin Hydrochloride i.p—500 mg (As sustained-release form) Excipients–q.s Colour: Sunset yellow fcf | |
| 3 | VOGLIBOSE, GLIMEPRIDE (1 MG) & METFORMIN HYDROCHLORIDE SUSTAINED-RELEASE TABLETS | Each film coated bi-layered tablet contains: Voglibose i.p—0.2 mg Glimepiride i.p–1 mg Metformin hydrochloride i.p—500 mg (As sustaned release form) Excipients–q.s Colour: lake of quinolinev yellow | |
| 4 | VOGLIBOSE, GLIMEPRIDE (2 MG) & METFORMIN HYDROCHLORIDE SUSTAINED-RELEASE TABLETS | Each film coated bi-layered tablet contains: Voglibose i.p—0.2 mg Glimepiride i.p–2 mg Metformin hydrochloride i.p—500 mg (As sustaned release form) Excipients–q.s Colour: lake of sunset yellow fcf | |
| 5 | METFORMIN HYDROCHLORIDE PROLONGED-RELEASE & GLIMEPIRIDE TABLETS I.P (500 MG + 1 MG) | Each film coated bi-layered tablet contains: Metformin Hydrochloride i.p—500 mg (As prolonged-release form) Glimepiride i.p—1 mg Excipients–q.s Colour: Erythrosine | |
| 6 | METFORMIN HYDROCHLORIDE PROLONGED-RELEASE & GLIMEPIRIDE TABLETS I.P (500 MG + 2 MG) | Each film coated bi-layered tablet contains: Metformin Hydrochloride i.p—500 mg (As prolonged-release form) Glimepiride i.p–2 mg Excipients–q.s Colour: Tartrazine | |
| 7 | METFORMIN HYDROCHLORIDE PROLONGED-RELEASE & GLIMEPIRIDE TABLETS I.P (1000 MG + 1 MG) | Each film coated bi-layered tablet contains: Metformin Hydrochloride i.p–1000 mg (As prolonged-release form) Glimepiride i.p—1 mg Excipients–q.s Colour: Erythrosine | |
| 8 | METFORMIN HYDROCHLORIDE PROLONGED-RELEASE & GLIMEPIRIDE TABLETS I.P (1000 MG + 2 MG) | Each film coated bi-layered tablet contains: Metformin Hydrochloride i.p—1000 mg (As prolonged-release form) Glimepiride i.p—2 mg Excipients–q.s Colour: Sunset yellow fcf & Titanium dioxide i.p | |
| 9 | VOGLIBOSE & METFORMIN HYDROCHLORIDE SUSTAINED-RELEASE TABLET ( 0.3 + 500 MG) | Each film coated tablet contains: Voglibose i.p— 0.3 mg Metformin Hydrochloride i.p— 500 mg (As sustained-release form) Excipients–q.s Colour: Tartrazine | |
| 10 | VOGLIBOSE & METFORMIN HYDROCHLORIDE SUSTAINED-RELEASE TABLET ( 0.2 + 500 MG) | Each film coated tablet contains: Voglibose i.p—0.2 mg Metformin Hydrochloride i.p—500 mg (As sustained release form) Excipients–q.s Colour: Sunset yellow fcf | |
| 11 | VOGLIBOSE & METFORMIN HYDROCHLORIDE SUSTAINED-RELEASE TABLETS (0.3+500MG) | Each film coated tablet contains: Voglibose i.p— 0.3 mg Metformin Hydrochloride i.p— 500 mg (As sustained-release form) Excipients–q.s Approved colur used | |
| 12 | VILDAGLIPTIN TABLETS 50 MG | Each film coated tablet contains: Vildagliptin— 50 mg Excipients—q.s Approved colours used | |
| 13 | VILDAGLIPTIN & METFORMIN HYDROCHLORIDE TABLETS (50MG+500MG) | Each film coated tablet contains: Vildagliptin— 50 mg Metformin Hydrochloride i.p— 500 mg Excipients–q.s Approved colurs used | |
| 14 | VILDAGLIPTIN & METFORMIN HYDROCHLORIDE TABLETS (50MG+1000MG) | Each film coated tablet contains: Vildagliptin— 50 mg Metformin Hydrochloride i.p— 1000 mg Excipients–q.s Approved colurs used | |
| 15 | 
| Each film coated tablet contains: Voglibose i.p— 0.2 mg Metformin Hydrochloride i.p— 500 mg (As sustained-release form) Excipients–q.s Approved colur used | |
| 16 | METFORMIN HCL & GLIMEPIRIDE & PIOGLITAZONE TABLETS | Each uncoated bilayered tablet contains: Metformin Hcl ip—500 mg (As extended release form) Glimepiride ip—1 mg Pioglitazone Hydrochloride ip eq. to Pioglitazone—15 mg Colour: Approved colours used | |
| 17 | VOGLIBOSE & METFORMIN HYDROCHLORIDE TABLETS (FOR EXPORT ONLY) | Each uncoated tablet co tains: Voglibose— 0.3 mg Metformin Hydrochloride BP— 500 mg Excipients:q.s Colour: Approved Colour Used. | |
| 18 | DAPAGLIFIOZIN TABLETS | Each Film Coated Tablets Contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin— 5 mg Excipients:q.s Colour: Approved colour used. | |
| 19 | DAPAGLIFIOZIN TABLETS | Each Film Coated Tablets Contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin— 10 mg Excipients:q.s Colour: Approved colour used. | |
| 20 | GLICLAZIDE & METFORMIN HYDROCHLORIDE TABLETS | Each uncoated tablet contains: Gliclazide I.P.—80 mg Metformin Hydrochloride I.P—500 mg Excipients—q.s Colour: Approved colour used. | |
| 21 | TENELIGLIPTIN AND METFORMIN HYDROCHLORIDE (EXTENDED RELEASE TABLETS) | Each uncoated bilayered tablet contains: Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin—20 mg Metformin Hydrochloride I.P—500 mg (As extended release) Excipienst—q.s Colour: Approved colour used. | |
| 22 | TENELIGLIPTIN AND METFORMIN HYDROCHLORIDE (EXTENDED RELEASE TABLETS) | Each uncoated bilayered tablet contains: Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin—20 mg Metformin Hydrochloride I.P—1000 mg (As extended release) Excipienst—q.s Colour: Approved colour used. | |
| 23 | GLIMEPIRIDE TABLETS IP 1 MG | Each uncoated tablet contains : Glimepiride I.P. 1 mg Excipients q.s. | |
| 24 | TENELIGLIPTIN TABLETS I.P 20MG | Each film coated tablet contains: Teneligliptin Hydrobromide Hydrate I.P eq. to Teneligliptin—20 mg Excipients: q.s Colour: Approved colour used. | |
| 25 | VILDAGLIPTIN TABLETS I.P 50 MG | Each film coated tablet contains: Vildagliptin I.P—50 mg Excipients:q.s Colour: Approved colour used. | |
| 26 | VILDAGLIPTIN & METFORMIN HYDROCHLORIDE TABLETS | Each film coated tablet contains: Vildagliptin I.P—50 mg Metformin Hydrochloride I.P—1000 mg Excipients—q.s Colour: Approved colour used. | |
| 27 | VILDAGLIPTIN & METFORMIN HYDROCHLORIDE TABLETS | Each film coated tablet contains: Vildagliptin I.P—50 mg Metformin Hydrochloride I.P—500 mg Excipients—q.s Colour: Approved colour used. | |
| 28 | GLICLAZIDE TABLETS IP 80 MG | Each uncoated tablet contains: Gliclazide I.P—80 mg Excipients—q.s | |
| 29 | VILDAGLIPTIN TABLETS I.P 50 MG | Each film coated tablet contains: Vildagliptin I.P—50 mg Excipients—q.s Colour: Approved colour used. | |
| 30 | DAPAGLIFIOZIN & METFORMIN HCL EXTENDED RELEASE TABLETS | Each film coated bi-layered tablet contains: Dapagliflozin —10 mg Metfromin Hcl I.P—500 mg (in extednde release form) Excipients–q.s Colour: Approved colour used. | |
| 31 | DAPAGLIFIOZIN & METFORMIN HCL EXTENDED RELEASE TABLETS | Each film coated bi-layered tablet contains: Dapagliflozin —5 mg Metfromin Hcl I.P—500 mg (in extednde release form) Excipients–q.s Colour: Approved colour used. | |
| 32 | TENELIGIIPTIN & METFORMIN HYDROCHLORIDE (EXTENDED RELEASE) TABLETS | Each film coated bi-layered tablets contains: Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin—20 mg Metformin Hydrochloride IP—1000 mg (as extended release form) Excipients—q.s Colour: Approved colour used. | |
| 33 | VILDAGLIPTIN & METFORMIN HYDROCHLORIDE TABLETS (50 MG + 500 MG) | Each film coated tablet contains: Vildagliptin—50 mg Metformin Hydrochloride I.P—500 mg Excipients—q.s Colour: Approved colour used. | |
| 34 | Epalrestat Sustained Release Tablets 50 mg | Each film coated tablet contains: Epalrestat—50 mg Excipients—q.s Colour: Approved colour used. | |
| 35 | GLIMEPIRIDE TABLETS IP | Each uncoated tablet contains: Glimepiride I.P—2 mg Excipients—q.s | |
| 36 | METFORMIN HYDROCHLORIDE PROLONGED RELEASE & GLIMEPIRIDE TABLETS IP | Each film coated bi-layered tablet contains: Metformin Hydrochloride I.P—500 mg (As prolonged release form) Glimepiride I.P—1 mg Excipients—q.s Colour: Approved colour used. | |
| 37 | METFORMIN HYDROCHLORIDE PROLONGED RELEASE & GLIMEPIRIDE TABLETS IP | Each film coated bi-layered tablet contains: Metformin Hydrochloride I.P—500 mg (As prolonged release form) Glimepiride I.P—2 mg Excipients—q.s Colour: Approved colour used. | |
| 38 | VILDAGLIPTIN & METFORMIN SR TABLETS | Each film coated bi-layered tablet conatins: Vildagliptin IP—50 mg Metformin Hydrochloride IP—500 mg (As sustained release ) Excipients—q.s Colour:Approved colour used. | |
| 39 | VILDAGLIPTIN & METFORMIN SR TABLETS | Each film coated bi-layered tablet conatins: Vildagliptin IP—50 mg Metformin Hydrochloride IP—1000 mg (As sustained release ) Excipients—q.s Colour:Approved colour used. | |
| 40 | METFROMIN HYDROCHLORIDE SUSTAINED RELEASE TABLETS I.P 850 MG | Each film coated sustained release tablet contains: Metformin Hydrochloride IP—850 mg Excipients—q.s Colour: Approved colour used. | |
| 41 | SITAGLIPTIN TABLETS I.P 25 MG | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate I.P eq. to Sitagliptin—25 mg Excipients—q.s colour: Approved colour used. | |
| 42 | SITAGLIPTIN TABLETS I.P 50 MG | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate I.P eq. to Sitagliptin—50 mg Excipients—q.s colour: Approved colour used. | |
| 43 | SITAGLIPTIN TABLETS I.P 100 MG | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate I.P eq. to Sitagliptin—100 mg Excipients—q.s colour: Approved colour used. | |
| 44 | SITAGLIPTIN PHOSPHATE & METFORMIN HYDROCHLORIDE TABLETS I.P 50 MG/500 MG | Each film coated tablet contains: 64.25 mg of Sitagliptin Phosphate Monohydrate I.P eq. to Sitagliptin—50 mg Metformin Hydrochloride I.P—500 mg Excipients—q.s colour: Approved colour used. | |
| 45 | SITAGLIPTIN PHOSPHATE & METFORMIN HYDROCHLORIDE TABLETS I.P 50 MG/850 MG | Each film coated tablet contains: 64.25 mg of Sitagliptin Phosphate Monohydrate I.P eq. to Sitagliptin—50 mg Metformin Hydrochloride I.P—850 mg Excipients—q.s colour: Approved colour used. | |
| 46 | SITAGLIPTIN PHOSPHATE & METFORMIN HYDROCHLORIDE TABLETS I.P 50 MG/1000 MG | Each film coated tablet contains: 64.25 mg of Sitagliptin Phosphate Monohydrate I.P eq. to Sitagliptin—50 mg Metformin Hydrochloride I.P—1000 mg Excipients—q.s colour: Approved colour used. | |
| 47 | VOGLIBOSE TABLETS IP 0.2 MG | Each uncoated tablet contains: Voglibose IP—0.2 mg Excipients—q.s | |
| 48 | VILDAGLIPTIN TABLETS IP 100 MG | Each uncoated tablet contains: Vildagliptin IP—100 mg Excipients—q.s Colour: Approved colour used. | |
| 49 | VILDAGLIPTIN TABLETS IP 50 MG | Each uncoated tablet contains: Vildagliptin IP—50 mg Excipients—q.s Colour: Approved colour used. | |
| 50 | REPAGLINIDE TABLETS IP 1 MG | Each uncoated tablet contains: Repaglinide IP—1 mg Excipients–q.s | |
| 51 | REPAGLINIDE TABLETS IP 0.5 MG | Each uncoated tablet contains: Repaglinide IP—0.5 mg Excipients–q.s | |
| CARDIOVASCULAR | |||
| S. No. | Generic Name | Composition | |
| S. No. | Generic Name | Composition | |
| 1 | ATORVASTATIN CALCIUM TABLET I.P 10 MG | Each film coated tablet contains: Atorvastatin Calcium i.p eq.to atorvastatin—10 mg Excipients–q.s Colour: Titanium dioxide i.p | |
| 2 | ATORVASTATIN CALCIUM TABLET I.P 20 MG | Each film coated tablet contains: Atorvastatin Calcium i.p eq.to atorvastatin—20 mg Excipients–q.s Colour: Titanium dioxide i.p | |
| 3 | BENIDIPINE HYDROCHLORIDE TABLETS 4 MG | Each uncoated tablet contains: Benidipine Hydrochlkoride—4 mg Excipients–q.s | |
| 4 | BENIDIPINE HYDROCHLORIDE TABLETS 8 MG | Each uncoated tablet contains: Benidipine Hydrochlkoride—8 mg Excipients–q.s | |
| 5 | CLONIDINE HYDROCHLORIDE TABLETS I.P 100 MCG | Each uncoated tablet contains: Clonidine hydrochloride i.p—100 mcg Excipients–q.s | |
| 6 | CLONIDINE HYDROCHLORIDE TABLETS I.P 150 MCG | Each uncoated tablet contains: Clonidine hydrochloride i.p—150 mcg Excipients–q.s | |
| 7 | PRAZOSIN HYDROCHLORIDE EXTENDED RELEASE TABLETS 2.5 MG | Each film coated tablet extended release contains: Prazosin Hydrochloride i.p eq. to prazosin—2.5 mg Excipients–q.s Colour: Ferric oxide red usp-nf & titanium dioxide i.p | |
| 8 | PRAZOSIN HYDROCHLORIDE EXTENDED RELEASE TABLETS 5 MG | Each film coated tablet extended release contains: Prazosin Hydrochloride i.p eq. to prazosin—5 mg Excipients–q.s Colour: Lake of ponceau-4r & titanium dioxide i.p | |
| 9 | AMLODIPINE TABLETS I.P 5 MG | Each uncoated tablet contains: Amlodipine Besilate i.p eq. to amlodipine—5 mg Excipients–q.s | |
| 10 | LABETALOL HYDROCHLORIDE I.P 50 MG | Each film coated tablet contains: Labetalol Hydrochloride i.p—50 mg Excipients–q.s Colour: Titanium dioxide i.p | |
| 11 | TELMISARTAN TABLETS I.P 40 MG | Each uncoated tablet contains: Telmisrtan i.p—40 mg Excipients–q.s | |
| 12 | CILNIDIPINE TABLETS I.P 20 MG | Each film coated tablet contains: Clinidipine i.p— 20 mg Excipients–q.s Approved colours used | |
| 13 | ROSUVASTATIN TABLETS I.P 10 MG | Each film coated tablet contains: Rosuvastatin i.p eq. to anhydrous rosuvastatin—10mg Excipients—q.s Approved colours used | |
| 14 | ROSUVASTATIN TABLETS I.P 20 MG | Each film coated tablet contains: Rosuvastatin i.p eq. to anhydrous rosuvastatin—20mg Excipients—q.s Approved colours used | |
| 15 | ROSUVASTATIN TABLETS I.P 40 MG | Each film coated tablet contains: Rosuvastatin i.p eq. to anhydrous rosuvastatin—40mg Excipients—q.s Approved colours used | |
| 16 | MINOXIDIL TABLETS I.P 5 MG | Each uncoated tablet contains: Minoxidil i.p— 5mg Excipients—q.s | |
| 17 | MINOXIDIL TABLETS I.P 10 MG | Each uncoated tablet contains: Minoxidil i.p— 10mg Excipients—q.s | |
| 18 | MINOXIDIL TABLETS I.P 2.5 MG | Each uncoated tablet contains: Minoxidil i.p— 2.5mg Excipients—q.s | |
| 19 | CILNIDIPINE TABLETS I.P 5 MG | Each film coated tablet contains: Clinidipine i.p— 5mg Excipients—q.s Approved colour used. | |
| 20 | CILNIDIPINE TABLETS I.P 10 MG | Each film coated tablet contains: Clinidipine i.p— 10mg Excipients—q.s Approved colour used. | |
| 21 | ROSUVASTATIN & FENOFIBRATE TABLET I.P | Each film coated tablet contains: Fenofibrate i.p— 160 mg Rosuvastatin calcium i.p eq. to rosuvastatin–10 mg Excipients–q.s Colour: Approved colour used | |
| 22 | EZETIMIBE TABLETS I.P 10 MG | Each uncoated tablet contains: Ezetimibe i.p–10 mg Excipients: q.s Colour: approved colour used. | |
| 23 | LOSARTAN POTASSIUM & HYDROCHLOROTHIAZIDE TABLETS I.P | Each uncoated tablet contains: Losartan Potassium ip— 50 mg Hydrochlorothiazide i.p— 12.5 mg Excipients–q.s | |
| 24 | FLUNARIZINE DIHYDROCHLORIDE TABLETS 10 MG | Each uncoated tablet contains: Flunarizine Dihydrochloride b.p eq. to Flunarizine—10 mg Excipients–q.s | |
| 25 | TELMISARTAN TABLETS I.P 20 MG | Each uncaoted tablet contains: Telmisartan i.p— 20 mg Excipients–q.s Colour: Approved colour used. | |
| 26 | BISOPROLOL FUMARATE TABLETS U.S.P. 2.5 MG | Each uncoated tablet contains: Bisoprolol Fumarate usp—2.5 mg Excipients–q.s | |
| 27 | RAMIPRIL TABLETS I.P 5 MG | Each uncoated tablet contains: Ramipril i.p—5 mg Excipients–q.s | |
| 28 | NICORANDIL TABLETS i.p 5 MG | Each uncoated tablet contains: Nicorandil i.p—5 mg Excipients–q.s | |
| 29 | ROSUVASTATIN CALCIUM & CLOPIDOGREL BISULPHATE TABLETS | Each film coated tablet contains: Rosuvastatin calcium ip eq. to Rosuvastatin—40 mg Clopidogrel Bisulphate eq. to Clopidogrel—75 mg Excipients—q.s Colour: Approved Colour used | |
| 30 | NEBIVILOL TABLETS IP | Each uncoated tablet contains: Nebivilol Hydrochloride ip eq. to Nebivilol—5 mg Excipients—q.s Colour: Approved colour used | |
| 31 | NEBIVILOL TABLETS IP | Each uncoated tablet contains: Nebivilol Hydrochloride ip eq. to Nebivilol—2.5 mg Excipients—q.s Colour: Approved colour used | |
| 32 | ROSUVASTATIN & FENOFIBRATE TABLETS IP | Each film coated tablet contains: Rosuvastatin Calcium IP eq. to Rosuvastatin—10 mg Fenofibrate IP—145 mg Excipients—q.s Colour: Approved colour used. | |
| 33 | AMLODIPINE BESYLATE TABLETS USP 5 MG | Each uncoated tablet contains: Amlodipine Besylate USP eq. to Amlodipine—5 mg Excipients–q.s Colour: Approved colour used. | |
| 34 | AMLODIPINE BESYLATE TABLETS USP 10 MG | Each uncoated tablet contains: Amlodipine Besylate USP eq. to Amlodipine—10 mg Excipients–q.s Colour: Approved colour used. | |
| 35 | TELMISARTAN TABLETS I.P 80 MG | Each uncoated tablet contains: Telmisartan I.P—80 mg Excipients—q.s Colour: Approved Colour Used. | |
| 36 | CARVEDILOL TABLETS I.P. | Each film coated tablet contains: Carvedilol I.P—3.125 mg Excipients—q.s Colour: Approved colour used. | |
| 37 | CARVEDILOL TABLETS I.P. | Each film coated tablet contains: Carvedilol I.P—6.25 mg Excipients—q.s Colour: Approved colour used. | |
| 38 | TELMISARTAN TABLETS I.P 20 MG (FILM COATED) | Each film coated tablet contains: Telmisartan–20 mg Excipients—q.s Colour: Approved colour used. | |
| 39 | TELMISARTAN TABLETS I.P 40 MG (FILM COATED) | Each film coated tablet contains: Telmisartan–40 mg Excipients—q.s Colour: Approved colour used. | |
| 40 | TELMISARTAN TABLETS I.P 80 MG (FILM COATED) | Each film coated tablet contains: Telmisartan–80 mg Excipients—q.s Colour: Approved colour used. | |
| 41 | TELMISARTAN & HYDROCHLORITHIAZIDE TABLETS IP | Each uncoated tablet contains: Telmisartan–40 mg Hydrochlorothiazide I.P—12.5 mg Excipients—q.s Colour: Approved colour used. | |
| 42 | CILNIDIPINE & METOPROLOL SUCCINATE (SR) TABLETS | Each film coated bi-layered tablet contains: Cilnidipine Succinate I.P—10 mg Metoprolol Succinate I.P— 47.50 mg Metoprolol Tartrate— 50 mg (in sustained release form) Excipients—q.s Colour: Approved colour used. | |
| 43 | CILNIDIPINE & METOPROLOL SUCCINATE (SR) TABLETS | Each film coated bi-layered tablet contains: Cilnidipine Succinate I.P—10 mg Metoprolol Succinate I.P— 23.75 mg Metoprolol Tartrate— 25 mg (in sustained release form) Excipients—q.s Colour: Approved colour used. | |
| 44 | CARVEDILOL TABLETS I.P. | Each film coated tablet contains: Carvedilol I.P—6.25 mg Excipients—q.s Colour: Approved colour used. | |
| 45 | HYDRATED DI-HYDRALAZINE SULFATE | Each film coated tablet contains : Hydrated Di-Hydralazine Sulfate B.P. 25 mg Excipient q.s. Colour : Approved colour used | |
| 46 | CANDESARTAN CILEXETIL TABLET USP 16 MG | Each uncoated tablet contains: Candesartan Cilexetile USP—16 mg Excipients: q.s | |
| 47 | CANDESARTAN CILEXETIL TABLET USP 8 MG | Each uncoated tablet contains: Candesartan Cilexetile USP—8 mg Excipients: q.s | |
| 48 | CILNIDIPINE & TELMISARTAN TABLETS | Each film coated tablet contains: Cilnidipine I.P—10 mg Telmisartan I.P—40 mg Excipeints:q.s Colour: Approved colour used. | |
| 49 | BISOPROLOL FUMARATE TABLETS U.S.P. | Each uncoated tablet contains: Bisoprolol Fumarate usp—5 mg Excipients–q.s | |
| 50 | BISOPROLOL FUMARATE & HYDROCHLOROTHIAZIDE TABLETS I.P | Each film coated tablet contains: Bisoprolol Fumarate i.p—5 mg Hydrochlorothiazide i.p—6.25 mg Excipients–q.s Colour: Approved colour used. | |
| 51 | BISOPROLOL FUMARATE & AMLODIPINE BESYLATE I.P | Each uncoated tablet contains: Bisoprolol Fumarate B.P—5 mg Amlodipine Besylate I.P—5 mg Excipients—q.s | |
| 52 | BISOPROLOL FUMARATE & AMLODIPINE BESYLATE I.P | Each uncoated tablet contains: Bisoprolol Fumarate B.P—2.5 mg Amlodipine Besylate I.P—5 mg Excipients—q.s | |
| 53 |
| Each film coated tablet contains: Bisoprolol Fumarate B.P—2.5 mg Amlodipine Besylate I.P eq. to Amlodipin—5 mg Excipients—q.s Colour: Approved colour used | |
| 54 | LOSARTAN POTASSIUM & HYDROCHLOROTHIAZIDE TABLETS I.P | Each uncoated tablet contains: Losartan Potassium IP— 50 mg Hydrochlorothiazide IP— 12.5 mg Excipients–q.s | |
| 55 | ROSUVASTATIN TABLETS I.P 10 MG | Each film coated tablet contains: Rosuvastatin I.P eq.to Anhydrous Rosuvastatin—10 mg Excipients—q.s Approved colour used | |
| 56 | ROSUVASTATIN TABLETS I.P 20 MG | Each film coated tablet contains: Rosuvastatin I.P eq.to Anhydrous Rosuvastatin—20 mg Excipients—q.s Approved colour used | |
| 57 | NEBIVILOL TABLETS IP | Each uncoated tablet contains: Nebivilol Hydrochloride IP eq. to Nebivilol—2.5 mg Excipients–q.s Colour: Approved colour used. | |
| 58 | NIFEDIPINE SUSTAINED RELEASE TABLETS IP | Each film coated sustained release tablet contains: Nifedipine IP—20mg Excipients—q.s Colour: Approved colour used. | |
| 59 | TELMISARTAN & METOPROLOL SUCCINATE TABLETS | Each film coated tablet contains: Telmisartan I.P—40 mg Metoprolol Succinate I.P—23.75 mg eq. to Metoprolol Tartrate I.P—25 mg Excipients—q.s Colour: Approved colour used. | |
| 60 | TELMISARTAN & METOPROLOL SUCCINATE TABLETS | Each film coated tablet contains: Telmisartan I.P—40 mg Metoprolol Succinate I.P—47.50 mg eq. to Metoprolol Tartrate I.P—50 mg Excipients—q.s Colour: Approved colour used. | |
| 61 | TELMISARTAN, CHLORTHALIDONE & METOPROLOL SUCCINATE (ER) TABLETS | Each film coated bilayer tablet contains: Telmisartan IP—40 mg Chlorthalidone I.P—12.5 mg Metoprolol Succinate I.P 47.50 mg eq. to Metoprolol Tartrate—50 mg (as extended release form) Excipients—q.s Colour: Approved colour used. | |
| 62 | CLINIDIPINE & CHLORTHALIDONE TABLETS | Each film coated tablet contains: Clinidipine I.P—10 mg Chlorthalidone I.P—12.5 mg Excipients—q.s Colour: Approved colour used. | |
| 63 | ROSUVASTATIN,ASPIRIN & CLOPIDOGREL TABLETS | Each film coated tablet contains: Rosuvastatin Calcium I.P eq. to Rosuvastatin—10 mg Aspirin I.P—75mg Clopidogrel Disulphate I.P eq. to Clopidogrel—75 mg Excipients—q.s Colour: Approved colour used | |
| 64 | TELMISARTAN & EXTENDED RELEASE METOPROLOL SUCINATE TABLETS | Each film coated bilayered tablet contains: Telmisartan IP—40 mg Metoprolol Succiante IP—47.5 mg eq. to Metoprolol Tartrate—50 mg (as extended release form) Excipients—q.s Colour: Approved colour used. | |
| 65 | CILNIDIPINE & METOPROLOL SUCCINATE (SR) TABLETS | Each film coated bi-layered tablet contains: Cilnidipine Succinate I.P—20 mg Metoprolol Succinate I.P—47.50 mg Metoprolol Tartrate—50 mg (in sustained release form) Excipients—q.s Colour: Approved colour used. | |
| 66 | FENOFIBRATE & ROSUVASTATIN TABLETS | Each film coated tablet conatains: Fenofibrate USP—160 mg Rosuvastatin Calcium USP eq. to Rosuvastatin—10 mg Excipients—q.s Colour: Approved colour used | |
| 67 | ATORVASTATIN TABLETS USP 10 MG | Each film caoted tablet contains: Atorvastatin Calcium USP eq. to Atorvastatin—10 mg Excipients—q.s Colour: Approved colour used | |
| 68 | ROSUVASTATIN TABLETS USP 10 MG | Each film coated tablet contains: Rosuvastatin Calcium USP eq. to Rosuvastatin—10 mg Excipients—q.s Colour: Approved colour used. | |
| 69 | ROSUVASTATIN TABLETS USP 20 MG | Each film coated tablet contains: Rosuvastatin Calcium USP eq. to Rosuvastatin—20 mg Excipients—q.s Colour: Approved colour used. | |
| 70 | OLMESARTAN MEDOXOMIL TABLETS IP 20 MG | Each film coated tablet contains: Olmesartan Medoxomil IP—20 mg Colour: Approved colour used. | |
| 71 | AMLODIPINE BESYLATE TABLETS I.P 5 MG | Each uncoated tablet contains: Amlodipine Besylate i.p eq. to amlodipine—5 mg Excipients–q.s | |
| 72 | ATORVASTATIN CALCIUM TABLETS IP 10 MG | Each film coated tablet contains: Atorvastatin Calcium i.p eq.to atorvastatin—10 mg Excipients–q.s Colour: Approved colour used. | |
| 73 | ROSUVASTATIN TABLETS IP 10 MG | Each film coated tablet contains: Rosuvastatin calcium i.p eq. to rosuvastatin–10 mg Excipients–q.s Colour: Approved colour used | |
| 74 | LOSARTAN POTASSIUM & HYDROCHLOROTHIAZIDE TABLETS I.P | Each uncoated tablet contains: Losartan Potassium ip— 50 mg Hydrochlorothiazide i.p— 12.5 mg Excipients–q.s | |
| 75 | TELMISARTAN, CHLORTHALIDONE & METOPROLOL SUCCINATE (ER) TABLETS | Each film coated bilayer tablet contains: Telmisartan IP—40 mg Chlorthalidone I.P—12.5 mg Metoprolol Succinate I.P 47.50 mg eq. to Metoprolol Tartrate—50 mg (as extended release form) Excipients—q.s Colour: Approved colour used. | |
| 76 | TELMISARTAN, CILNIDIPINE & METOPROLOL SUCCINATE (ER) TABLETS | Each film coated bilayer tablet contains: Telmisartan IP—40 mg Cilnidipine—10 mg Metoprolol Succinate I.P 47.50 mg eq. to Metoprolol Tartrate—50 mg (as extended release form) Excipients—q.s Colour: Approved colour used. | |
| 77 | Minoxidil Tablets IP 10 mg | Each uncoated tablet contains: Minoxidil I.P—10 mg Excipients—q.s | |
| 78 | TELMISARTAN & AMLODIPINE TABLETS IP | Each uncoated bilayered tablet contains: Telmisartan IP—40 mg Amlodipine Besylate IP eq. to Amlodipine—5 mg Excipients—q,s Colour: Approved colour used. | |
| 79 | FENOFIBRATE & ROSUVASTATIN TABLETS
| Each film coated tablet contains: Fenofibrate I.P— 160 mg Rosuvastatin Calcium I.P eq. to Rosuvastatin–20 mg Excipients–q.s Colour: Approved colour used | |
| 80 | TELMISARTAN & AMLODIPINE TABLETS IP | Each film coated tablet contains: Telmisartan IP—40 mg Amlodipine Besylate IP eq. to Amlodipine—5 mg Excipients—q,s Colour: Approved colour used. | |
| 81 | NICORANDIL TABLETS I.P 5 MG | Each uncoated tablet contains: Nicorandil i.p—5 mg Excipients–q.s | |
| 82 | TELMISARTAN & HYDROCHLORITHIAZIDE TABLETS IP | Each uncoated bi-layered tablet contains: Telmisartan I.P—40 mg Hycrochlorithazide I.P—12.5 mg Excipients—q.s Colour: Approved colour used. | |
| 83 | BETHANECHOL CHLORIDE 25 MG U.S.P. | Each uncoated tablet contains: Bethanechol Chloride U.S.P—25 mg Excipients—q.s | |
| 84 | TELMISARTAN & HYDROCHLORITHIAZIDE TABLETS IP | Each uncoated bi-layered tablet contains: Telmisartan I.P—80 mg Hycrochlorithazide I.P—12.5 mg Excipients—q.s Colour: Approved colour used. | |
| 85 | CARVEDILOL 12.5 mg TABLETS I.P. | Each film coated tablet contains: Carvedilol I.P—12.5 mg Excipients—q.s Colour: Approved colour used. | |
| 86 | CARVEDILOL PHOSPHATE EXTENDED RELEASE 10 MG TABLET | Each film coated extended release tablet contains: Carvedilol Phosphate Hemihydrate eq. to Carvedilol Phosphate—10 mg Excipients—q.s Colour: Approved colour used. | |
| 87 | CARVEDILOL PHOSPHATE EXTENDED RELEASE 20 MG TABLET | Each film coated extended release tablet contains: Carvedilol Phosphate Hemihydrate eq. to Carvedilol Phosphate—20 mg Excipients—q.s Colour: Approved colour used. | |
| 88 | CILNIDIPINE TABLETS I.P 10 MG | Each film coated tablet contains: Cilnidipine I.P—10 mg Excipients—q.s colour: Approved colour used. | |
| 89 | TELMISARTAN TABLETS I.P 20 MG | Each unoated tablet contains: Telmisartan I.P—20 mg Excipients—q.s Colour: Approved colour used. | |
| 90 | MINOXIDIL TAB LETS I.P 5 MG | Each uncoated tablet contains: Minoxidil I.P—5 mg Excipients—q.s | |
| 91 | METOPROLOL SUCCINATE EXTENDED RELEASE TABLETS IP 50 MG | Each film coated tablet extended release tablet contains: Metoprolol Succinate I.P—47.50 mg Metoprolol Tartrate—50 mg Excipients—q.s Colour: Approved colour used. | |
| 92 | NEBIVILOL TABLETS IP 5 MG | Each film coated tablet contains: Nebivolol Hydrochloride I.P eq.to Nebivolol—5 mg Excipients—q.s Colour: Approved colour used. | |
| 93 | TRIMETAZIDINE HYDROCHLORIDE IP 80 MG TABLETS | Each film coated tablet contains: Trimetazidine Hydrochloride IP—80 mg Excipients—q.s Colour: Approved colour used. | |
| 94 | TELMISARTAN TABLETS IP 40 MG | Each uncoated tablet contains: Telmisartan IP—40 mg Excipients—q.s | |
| 95 | CARVEDILOL TABLETS IP | Each film coated tablet contains: Carvedilol IP—3.125 mg Excipients—q.s Colour: Approved colour used | |
| 96 | CILNIDIPINE TABLETS IP | Each film coated tablet contains: Cilnidipine IP—20 mg Excipinets—q.s Colour: Approved colour used | |
| 97 | CARVEDILOL PHOSPHATE EXTENDED RELEASE 10 MG TABLET | Each film coated extended release tablet contains: Carvedilol Phosphate Hemihydrate eq. to Carvedilol Phosphate—10 mg Excipients—q.s Colour: Approved colour used. | |
| 98 | CARVEDILOL PHOSPHATE EXTENDED RELEASE 20 MG TABLET | Each film coated extended release tablet contains: Carvedilol Phosphate Hemihydrate eq. to Carvedilol Phosphate—20 mg Excipients—q.s Colour: Approved colour used. | |
| 99 | CARVEDILOL 12.5 mg TABLETS I.P. | Each film coated tablet contains: Carvedilol I.P—12.5 mg Excipients—q.s Colour: Approved colour used. | |
| 100 | ATORVASTATIN & CLOPIDOGREL TABLETS | Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin—80 mg Clopidogrel Bisulphate IP eq. to Clopidogrel—75 mg Excipients—q.s Colour: Approved colour used | |
| 101 | ATORVASTATIN & CLOPIDOGREL TABLETS | Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin—10 mg Clopidogrel Bisulphate IP eq. to Clopidogrel—75 mg Excipients—q.s Colour: Approved colour used | |
| 102 | OLMESARTAN MEDOXOMIL TABLETS IP 40 MG | Each film coated tablet contains: Olmesartan Medoxomil IP—40 mg Excipients—q.s Colour: Approved colour used. | |
| 103 | LOSARTAN POTASSIUM TABLETS I.P 50 MG | Each film coated tablet contains: Losartan Potassium I.P—50 mg Excipients–q.s Colour: Approved colour used. | |
| 104 | LOSARTAN POTASSIUM TABLETS I.P 100 MG | Each film coated tablet contains: Losartan Potassium I.P—100 mg Excipients–q.s Colour: Approved colour used. | |
| 105 | METOPROLOL SUCCINATE PROLONGED RELEASE AND AMLODIPINE TABLETS | Each film coated tablet contains: Metoprolol Succinate USP—47.5 mg eq. to Metoprolol Tartarate—50 mg (as prolonged release) Amlodipine Besylate USP eq. to Amlodipine—5 mg Excipients—q.s Colour: Approved colour used. | |
| 106 | TRIMETAZIDINE DIHYDROCHLORIDE SUSTAINED RELEASE TABLETS | Each film coated sustained release tablet contains: Trimetazidine Dihydrochloride—35 mg Excipients—q.s Colour: Approved colour used. | |
| 107 | FLUNARIZINE DIHYDROCHLORIDE AND PROPRANOLOL HYDROCHLORIDDE TABLETS | Each film coated tablet contains: Propranolol Hydrochloride IP—20 mg Flunarizin Dihydrochloride BP eq. to Flunarizine—5 mg Excipients—q.s Colour: Approved colour used. | |
| 108 | NIFEDIPINE EXTENDED RELEASE TABLETS USP 30 MG | Each extended release film coated tablet contains: Nifedipine USP—30 mg Excipients—q.s Colour: Approved colour used. | |
| 109 | CLONIDINE HYDROCHLORIDE TABLETS IP 100 MCG | Each uncoated tablet contains: Clonidine Hydrochloride IP—150 mg Excipients—q.s | |
| 110 | ATORVASTATIN & CLOPIDOGREL TABLETS | Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin—20 mg Clopidogrel Bisulphate IP eq. to Clopidogrel—75 mg Excipients–q.s Colour: Approved colour used. | |
| ANTACID AND PPI | |||
| S. No. | Generic Name | Composition | |
| S. No. | Generic Name | Composition | |
| 1 | SODIUM BICARBONATE TABLETS USP 1000 MG | Each film coated tablet contains: Sodium bicarbonate u.s.p.—1000 mg Excipients–q.s Colour: Titanium dioxide i.p | |
| 2 |
| Each film coated tablet contains: Sodium bicarbonate u.s.p.—500 mg Excipients–q.s Colour: Titanium dioxide i.p | |
| 3 | MAGNESIUM OXIDE TABLETS 400 MG | Each film coated tablet contains: Light Magnesium Oxide i.p—400 mg eq. to elemental magnesium—241.2 mg Excipients–q.s Colour: Quinoline yellow | |
| 4 | RABEPRAZOLE SODIUM & DOMPERIDONE TABLETS | Each enteric coated tablet contains: Rabeprazole sodium i.p—20 mg Domperidone i.p—10 mg Excipients–q.s Colour: Ferric oxide yellow usp-nf & titanium dioxide i.p | |
| 5 | PANTOPRAZOLE GASTRO-RESISTANT TABLETS I.P 40 MG | Each enteric coated tablet contains: Pantoprazole sodium i.p eq.to Pantoprazole—40 mg Excipients–q.s Cololur: Ferric oxide yellow usp-nf & titanium dioxide i.p | |
| 6 | PANTOPRAZOLE & DOMPERIDONE TABLETS | Each enteric coated tablet contains: Pantoprazole sodium i.p eq.to Pantoprazole—40 mg Domperidone i.p—10 mg Excipients–q.s Cololur: Lake of sunset yellow fcf & titanium dioxide i.p | |
| 7 | RABEPRAZOLE GASTRO-RESISTANT TABLETS I.P 20 MG | Each enteric coated tablet contains: Rabeprazole sodium i.p—20 mg Excipients–q.s Colour: Lake of sunset yellow fcf & titanium dioxide i.p | |
| 8 | RABEPRAZOLE GASTRO-RESISTANT TABLETS I.P 20 MG | Each enteric coated tablet contains: Rabeprazole sodium i.p—20 mg Excipients–q.s Colour: Approved colour used | |
| 9 | ESOMEPRAZOLE GASTRO-RESISTANT TABLETS I.P 40 MG | Each gastro-resistant tablet contains: Esomeprazole Magnesium Trihydrate I.P eq. to Esomeprazole—40 mg Excipients–q.s Colour: Approved colour used. | |
| 10 | SODIUM BICARBONATE TABLET USP 500 MG | Each film coated tablet contains: Sodium Bicarbonate I.P—500 mg Excipients—q.s Colour: Titanium Dioxide IP | |
| 11 | SODIUM BICARBONATE TABLET USP 11000 MG | Each film coated tablet contains: Sodium Bicarbonate I.P—1000 mg Excipients—q.s Colour: Titanium Dioxide IP | |
| 12 | ESOMEPRAZOLE GASTRO-RESISTANT TABLETS | Each enteric coated tablet contains: Esomeprazole Magnesium Trihydrate BP eq. to Esomeprazole—40 mg Excipients—q.s Colour: Approved colour used | |
| 13 | ESOMEPRAZOLE GASTRO-RESISTANT TABLET | Each enteric coated tablet contains: Esomeprazole Magnesium Trihydrate B.P eq. to Esomeprazole—40 mg Excipients–q.s Colour: Approved colour used. | |
| 14 | PANTOPRAZOLE & DOMPERIDONE TABLETS | Each enteric coated tablet contains: Pantoprazole sodium i.p eq.to Pantoprazole—40 mg Domperidone i.p—10 mg Excipients–q.s Cololur: Approved colour used. | |
| 15 | OXETACAINE, MAGALDRATE & DICYCLOMINE HYDROCHLORIDE TABLETS | Each film caoted tablet contains: Oxetacaine BP—5 mg Magaldrate (as anhydrous) IP—400 mg Dicyclomine Hydrochloride IP—10 mg Excipients—q.s Colour: Approved colour used. | |
| 16 | RANITIDINE TABLETS I.P | Each film coated tablet contains: Ranitidine Hydrochloride I.P—150 mg Excipients—q.s Colour: Approved colour used. | |
| 17 | ENTERIC COATED SODIUM BICARBONATE TABLETS 500 MG | Each enteric coated tablet contains: Sodium Bicarbonate I.P—500 mg Excipients—q.s Colour: Approved colour used. | |
| 18 | ENTERIC COATED SODIUM BICARBONATE TABLETS 500 MG | Each enteric coated tablet contains: Sodium Bicarbonate I.P—1000 mg Excipients—q.s Colour: Approved colour used. | |
| 19 | RANITIDINE HYDROCHLORIDE 150 MG TABLETS I.P | Each film coated talet contains: Ranitindine Hydrochloirde I.P eq. to Ranitidine—150 mg Excipients—q.s Colour: Approved colour used. | |
| ANTI-HISTAMINIC | |||
| S. No. | Generic Name | Composition | |
| 1 | LEVOCETIRIZINE HYDROCHLORIDE & MONTELUKAST DISPERSIBLE TABLETS | Each uncoated dispersible tablet contains: Montelukast sodium i.p eq.to Montelukast— 4mg Levocetrizine Hydrochloride I.p—2.5 mg Excipients–q.s Colour: Tartazine | |
| 2 | MONTELUKAST SODIUM & LEVOCETIRIZINE HYDROCHLORIDE TABLETS I.P | Each film coated tablet contains: Montelukast sodium i.p eq. to Montelukast—10 mg Levocetrizine hydrochloride i.p—5 mg Excipients–q.s Colour: Titanium dioxide i.p | |
| 3 | LEVOCETIRIZINE HYDROCHLORIDE TABLETS I.P 5 MG | Each film cotaed tablet contains: Levocetirizine Hydrochloride i.p—5 mg Excipients–q.s Colour: Titanium dioxide i.p | |
| 4 | LEVOCETIRIZINE & MONTELUKAST TABLETS I.P | Each uncoated bi-layered tablet contains: Levocetirizine Hydrochloride i.p–5 mg Montelukast Sodium ip eq. to montelukast—10 mg Excipients–q.s Colour: Approved colour used | |
| 5 | FEXOFENADINE HYDROCHLORIDE & MONTELUKAST SODIUM TABLETS | Each film coated tablet contains: Fexofenadine Hydrochloride i.p— 120 mg Montelukast Sodium i.p eq. to Montelukast –10 mg Excipients–q.s Colour: Approved colour used | |
| 6 | FEXOFENADINE HYDROCHLORIDE TABLETS I.P 180 MG | Each film coated tabhlet contains: Fexofenadine hydrochloride i.p—180 mg Excipients–q.s Colour: Approved colour used | |
| 7 | EBASTINE TABLETS I.P 20 MG | Each film coated tablet contains: Ebastine i.p—20 mg Excipients–q.s Ccolour: Approved colour used | |
| 8 | FEXOFENADINE HYDROCHLORIDE TABLETS I.P 120 MG | Each film coated tablet contains: Fexofenadine Hydrochloride IP–120 mg Excipients—q.s Colour: Approved colour used. | |
| 9 | LEVOCETIRIZINE HYDROCHLORIDE TABLETS I.P 10 MG | Each uncoated tablet contains: Levocetirizine Hydrochloride I.P—10 mg Excipients—q.s | |
| 10 | HYDROXIZINE HYDROCHLORIDE TABLETS I.P 25 MG | Each film coated tablet contains: Hydroxyzine Hydrochloride IP—25 mg Excipients—q.s Colour: Approved colour used. | |
| 11 | EBASTINE DISPERSIBLE TABLETS I.P 10 MG | Each Uncoated Dispersible Tablet contains : Ebastine I.P. 10 mg Excipients q.s. | |
| 12 |
| Each Uncoated Dispersible Tablet contains : Ebastine I.P. 20 mg Excipients | |
| 13 | FEXOFINADINE HYDROCHLORIDEtABLETS BP 180MG BRAND NAME: FEXOFA 180 | Each film coated tablet contains: Fexofinadine Hydrochloride BP—180 mg Excipients–q.s Colour: Approved colour used. | |
| 14 | FEXOFENADINE HYDROCHLORIDE TABLETS I.P 180 MG | Each film coated tablet contains: Fexofenadine Hydrochloride I.P—180 mg Excipients—q.s Colour: Approved colour used. | |
| 15 | BILASTINE & MONTELUKAST TABLET | Each film coated tablet contains: Bliastine—20 mg Montelukast Sodium IP eq. to Montelukast—10 mg Excipients—q.s Colour: Approved colour used | |
| 16 | MONTELUKAST SODIUM & LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS | Each film coated tablet contains: Levocetirizine Dihydrochloride USP—5 mg Montelukast sodium BP eq. to Montelukast—10 mg Excipients—q.s Colour: Approved colour used | |
| 17 | MONTELUKAST SODIUM & LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS | Each film coated tablet contains: Levocetirizine Dihydrochloride USP—5 mg Montelukast sodium BP eq. to Montelukast—10 mg Excipients—q.s Colour: Approved colour used | |
| 18 | LEVOCETIRIZINE & MONTELUKAST BI-LAYERED TABLETS | Each uncoated bi-layered tablet contains: Levocetirizine Dihydrochloride–5 mg Montelukast Sodium eq. to montelukast—10 mg Excipients–q.s Colour: Approved colour used | |
| 19 | BETAHISTINE DIHYDROCHLORIDE TABLETS I.P 16 MG | Each film coated tablet contains: Betahistine Dihydochloride i.p— 16 mg Excipients–q.s Colour: Ferric oxide (yellow) usp-nf lake of indigo carmine | |
| 20 |
| Each uncoated tablet contains: Betahistine Hydrochloride IP—24 mg Excipients: q.s Colour: Approved colour used. | |
| 21 | BETAHISTINE HYDROCHLORIDE TABLETS IP | Each uncoated tablet contains: betahistine Hydrochloride IP—16 mg Excipients: q.s Colour: Approved colour used. | |
| 22 | BETAHISTINE HYDROCHLORIDE TABLETS IP | Each uncoated tablet contains: Betahistine Hydrochloride IP—24 mg Excipients: q.s Colour: Approved colour used. | |
| 23 | BETAHISTINE HYDROCHLORIDE TABLETS IP 16 MG | Each film coated tablet contains: Betahistine Dihydochloride i.p— 16 mg Excipients–q.s Colour: Approved Colour Used. | |
| 24 | BETAHISTINE HYDROCHLORIDE TABLETS I.P | Each uncoated tablet contains: Betahistidine Hydrochlorider IP—16 mg Excipients—q.s | |
| IMMUNO-MODULATOR | |||
| S. No. | Generic Name | Composition | |
| 1 | SIROLIMUS 1 MG TABLETS | Each film coated tablet contains: Sirolimus—1 mg Excipients–q.s | |
| 2 | AZITHROPINE TABLETS I.P 75 MG | Each uncaoted tablet contains: Azathioprine i.p—75 mg Excipients–q.s | |
| 3 | 
| Each uncaoted tablet contains: Azathioprine i.p—100 mg Excipients–q.s | |
| 4 | AZITHROPINE TABLETS I.P 25 MG | Each film tablet contains: Azathioprine i.p—25 mg Excipients–q.s Colour: Titanium dioxide i.p | |
| 5 | AZITHROPINE TABLETS I.P 50 MG | Each film caoted tablet contains: Azathioprine i.p—50 mg Excipients–q.s Colour: Titanium dioxide i.p | |
| 6 | AZITHROPINE TABLETS I.P 75 MG | Each uncaoted tablet contains: Azathioprine i.p—75 mg Excipients–q.s Colour: Titanium dioxide i.p | |
| 7 | 
| Each uncaoted tablet contains: Azathioprine i.p—100 mg Excipients–q.s Colour: Titanium dioxide i.p | |
| 8 | AZITHROPINE TABLETS I.P 25 MG | Each uncaoted tablet contains: Azathioprine i.p—25 mg Excipients–q.s | |
| 9 | AZITHROPINE TABLETS I.P 50 MG | Each uncaoted tablet contains: Azathioprine i.p—50 mg Excipients–q.s | |
| 10 | MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS USP 360 MG | Each enteric coated tablet contains: Mycophenoloate sodium usp eq. to Mycophenolic acid—360 mg Excipients–q.s Colour: Titanium dioxide i.p | |
| 11 | MYCOPHENOLATE MOFETIL TABLETS I.P 500 MG | Each film coated tablet contains: Mycophenoloate mofetile i.p—500 mg Excipients–q.s Colour: Ferric oxide red usp-nf & Titanium dioxide i.p | |
| 12 | S-ADENOSYL L-METHIONINE TABLETS | Each film coated tablet contains: S-Adenosyl-L-Methionine 400 mg Excipients—q.s Colour: Approved colour used. | |
| 13 | MYCOPHENOLATE MOFETIL TABLETS I.P 250 MG | Each enteric coated yablet contains: Mycophenolate Mofetile I.P—250 mg Excipients—q.s Colour: Approved colour used. | |
| 14 | MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS 180 MG | Each enteric coated tablet contains: Mycophenolate sodium usp eq. to Mycophenolate Acid—180 mg Excipients—q.s Colour: Approved colour used. | |
| 15 | MYCOPHENOLATE MOFETILE TABLETS IP 250 MG | Each film coated tablet contains: Mycophenolate Mofetil IP—250 mg Excipients—q.s Colour: Approved colour used. | |
| 16 | TOFACITINIB TABLET 5 MG | Each film coated tablet contains: Tofacitinib Citrate eq. to Tofacitinib—5 mg Excipients—q.s Colour: Approved colour used. | |
| 17 | AZATHIOPRINE TABLETS I.P 50 MG | Each uncoated tablets contains: Azathioprine I.P—50 mg Excipients—q.s | |
| 18 | TOFACITINIB TABLET 5 MG | Each film coated tablet contains: Tofacitinib Citrate eq. to Tofacitinib—5 mg Excipients—q.s Colour: Approved colour used. | |
| 19 | MYCOPHENOLIC ACID DELAYED-RELEASE TABLET U.S.P. 360 MG | Each delayed-release tablet contains: Mycophenolate Sodium U.S.P. eq. to Mycophenolic Acid—360 mg Excipients—q.s Colour: Approved colour used. | |
| 20 | MYCOPHENOLATE MOFETIL TABLETS IP 250 MG | Each film coated tablet contains: Mycophenolate Mofetil IP—250 mg Excipients—q.s Colour: Approved colour used. | |
| 21 | S-ADENOSYL L-METHIONINE 200 MG TABLETS | Each film coated tablet contains: S-Adenosyl-L-Methionine 200 mg Excipients—q.s Colour: Approved colour used. | |
| 22 | AZARHIOPRINE TABLETS IP 50 MG | Each uncoated tablet contains: Azathioprine IP—50 mg Excipients—q.s | |
| ANTIBACTERIAL | ||
| S. No. | Generic Name | Composition |
| 1 | CLINDAMYCIN PHOSPHATE, CLOTRIMAZOLE & METRONIDAZOLE VAGINAL TABLETS | Each uncaoted tablet contains: Clindamycin phosphate i.p eq. to Clindamycin—100 mg Clotrimazole i.p—100 mg Metronidazole i.p—100 mg Excipients–q.s |
| 2 | DEFLAZAORT TABLETS 6 MG | Each uncoated tablet contains: Deflazacort—6 mg Excipients–q.s Colour: Erthrosine |
| 3 | DEFLAZACORT TABLETS 12MG | Each uncoated tablet contains: Deflazacort—12 mg Excipients–q.s Colour: Erthrosine |
| 4 | DEFLAZACORT TABLETS 30 MG | Each uncoated tablet contains: Deflazacort—30 mg Excipients–q.s Colour: Tartrazine |
| 5 | IVERMECTIN TABLETS 12 MG | Each uncoated tablet contains: Ivermectin ip— 12 mg Excipients–q.s Colour: approved colours used |
| 6 | ALBENDAZOLE & IVERMECTINE CHEWABLE TABLETS | Each uncoated chewable tablet contains: Albendazole I.P—400 mg Ivermectine I.P—12 mg Excipients—q.s Colour: Approved colour used. |
| 7 | TINIDAZOLE TABLETS (FOR EXPORT ONLY) | Each film coated tablets contains: Tinidazole USP—600 mg Excipients—q.s Colour: Approved colour used. |
| 8 | CIPROFLOXACIN & TINIDAZOLE TABLETS (FOR EXPORT ONLY ) | Each film coated tablet contains: Ciprofloxacin hydrochloride BP eq. to Ciprofloxacin—500 mg Tinidazole BP—600 mg Excipients—q.s Colour: Approved colour used. |
| CNS DRUGS | |||
| S. No. | Generic Name | Composition | |
| 1 | DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS I.P 250 MG | Each film coated tablet contains:
Divalporex Sodium i.p eq. to valproik acid—250 mg Excipients–q.s Colour: Ferric oxide (yellow) usp-nf & titanium dioxide i.p | |
| 2 | DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS I.P 500 MG | Each film coated tablet contains:
Divalporex Sodium i.p eq. to valproik acid—500 mg Excipients–q.s Colour: Ferric oxide (yellow) usp-nf & titanium dioxide i.p | |
| 3 | DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS I.P 750 MG | Each film coated tablet contains:
Divalporex Sodium i.p eq. to valproik acid—750 mg Excipients–q.s Colour: Lake of sunset yellow fcf & titanium dioxide i.p | |
| 4 | ESCITALOPRAM TABLETS I.P 5 MG | Each uncoated tablet contains:
Escitalopram Oxalate i.p eq. to Escitalopram—5mg Excipients–q.s Colour: Tartrazine | |
| 5 | DOTHIEPIN HYDROCHLORIDE TABLETS I.P 75 MG | Each film coated tablet contains:
Dothiepin hydrochloride i.p–75 mg Excipients–q.s Colour- Approved colour used | |
| 6 | SERTRALINE TABLETS I.MEBP. 50 MG | Each film coated tablet contains:
Sertraline Hydrochloride i.p eq. to Sertraline— 50 mg Excipients—q.s Colours:- Approved colours used | |
| 7 | PAROXETINE PROLONGED-RELEASE TABLETS I.P 25 MG | Each film coated controlled release tablet contains:
Paroxetine Hydrochloride i.p eq. to paroxetin—25 mg Excipients—q.s Colour: Approved colours used | |
| 8 | SODIUM VALPROATE WITH VALPROIC ACID CONTROLLED RELEASE TABLETS 500 MG | Each film coated controlled release tablet contains:
Sodium Valproate i.p—333 mg Valproic acid i.p— 145 mg (Both together corresponds to sodium valporate i.p 500 mg) Excipients–q.s Colour: Approved colour used. | |
| 9 | DULOXETINE GASTRO RESISTANT TABLETS I.P 20 MG | Each gastro-resistant tablet contains:
Duloxetine hcl i.p eq. to Duloxetine—20 mg Excipients–q.s Colour: Approved colour used. | |
| 10 | FLUPENTIXOL TABLETS BP 0.5 MG | Each film coated tablet contains:
Flupentixol Hydrochloride b.p eq. to Flupentixol—0.5mg Excipients Colour: Approved colours used | |
| 11 | LEVETIRACETAM TABLETS IP 250 MG | Each film coated tablet contains:
Levetiracetam i.p–250 mg Excipients q.s Colour: Approved colours used | |
| 12 | LEVETIRACETAM TABLETS IP 500 MG | Each film coated tablet contains:
Levetiracetam i.p–500 mg Excipients q.s Colour: Approved colours used | |
| 13 | FLUPENTHIXOL & MELITRACEN TABLETS | Each sugar coated tablet contains:
Flupenthixol IP—0.5 mg Melitracen HCL eq. to Melitracen—10 mg | |
| 14 | LEVETIRACETAM TABLETS I.P 500 MG | Each film coated tablet contaiins:
Levetiracetam I.P—500 mg Excipients—q.s Colour: Approved colour used. | |
| 15 | MIRTAZAPINE TABLETS U.S.P. 15 MG | Each film coated tablet contains:
Mirtazapine U.S.P—15 mg Excipients–q.s Colour: Approved colour used. | |
| 16 | TOPIRAMATE TABLETS I.P 50 MG | Each film coated tablet contains:
Topiramate I.P—50 mg Excipients—q.s Colour: Approved colour used. | |
| 17 | TOPIRAMATE TABLETS I.P 100 MG | Each film coated tablet contains:
Topiramate I.P—100 mg Excipients—q.s Colour: Approved colour used. | |
| 18 | CITICOLINE & PIRACETAM TABLETS | Each film coated tablets contains:
Citicoline Sodium I.P eq.to Citicoline—500 mg Piracetam I.P—800 mg Excipients—q.s Colour: Approved colour used. | |
| 19 | SERTALINE HYDROCHLORDIE TABLETS I.P 25 MG | Each film coated tablet contains:
Sertraline Hydrochloride IP—25 mg Excipients—q.s Colour: Approved colour used. | |
| 20 | SERTALINE HYDROCHLORDIE TABLETS I.P 100 MG | Each film coated tablet contains:
Sertraline Hydrochloride IP—100 mg Excipients—q.s Colour: Approved colour used. | |
| 21 | CITICOLINE & PIRACETAM TABLETS | Each film coated tablets contains:
Citicoline Sodium I.P eq.to Citicoline—500 mg Piracetam I.P—400 mg Excipients—q.s Colour: Approved colour used. | |
| 22 | PHENYTOIN TABLETS IP 100MG | Each film coated tablet contains:
Phenytoin Sodium I.P—100 mg Excipients—q.s Colour: Approved colour used. | |
| 23 | OLANZAPINE TABLETS I.P 5 MG | Each film coated tablet contains:
Olanazapine IP—5 mg Excipients—q.s Colour: Approved colour used. | |
| 24 | OLANZAPINE TABLETS I.P 10 MG | Each film coated tablet contains:
Olanazapine IP—10 mg Excipients—q.s Colour: Approved colour used. | |
| 25 | 
| Each uncoated tablet contains :
Rasagiline Mesylate Equivalent to Rasagiline 1 mg Excipients | |
| 26 | RASAGALINE TABLETS 0.5 MG | Each uncoated tablet contains :
Rasagiline Mesylate Equivalent to Rasagiline 0.5 mg Excipients | |
| 27 | FLUPENTIXOL & MELITRACEN TABLETS | Each film coated tablet contains :
Flupentixol Hydrochloride B.P. Eq. to Flupentixol 0.5 mg Melitracen Hydrochloride Eq. to Melitracen 10 mg Excipient q.s. Colour : Approved colour used in tablet | |
| 28 | PAROXETIN PROLONGDE-RELEASE TABLETS IP | Each film coated prolonged release tablet contains :
Paroxetine Hydrochloride I.P. Eq. to Paroxetine 12.5 mg Excipients q.s. Colour : Approved colour used | |
| 29 | AMITRIPTYLINE HYDROCHLORIDE TABLETS IP 25 MG | Each film coated tablet contains:
Amitriptyline Hydrochloride IP—25 mg Excipients—q.s Colour: Approved colour used. | |
| 30 | FLUPENTIXOL TABLETS BP 0.5 MG | Each film coated tablet contains:
Flupentixol Hydrochloride b.p eq. to Flupentixol—0.5mg Excipients Colour: Approved colours used | |
| 31 | SODIUM VALPORATE WITH VALPROIC ACID CONTROLLED RELEASE TABLETS 500MG | Each film coated controlled release tablet contains:
Sodium Valproate i.p—333 mg Valproic acid i.p— 145 mg (Both together corresponds to sodium valporate i.p 500 mg) Excipients–q.s Colour: Approved colour used. | |
| 32 | DULOXETINE GASTRO RESISTANT TABLETS I.P 30 MG | Each Gastro-resistant tablet contains:
Duloxetine Hydrochloride IP eq. to Duloxetine—30 mg | |
| 33 | SERTRALINE HYDROCHLORIDE TABLETS USP
| Each film coated tablet contains:
Sertraline Hydrochloride USP eq. to Sertraline—25 mg Excipients—q.s Colour: Approved colour used. | |
| 34 | OLANZAPINE MOUTH DISSOLVING TABLETS
| Each uncoted mouth dissolving tablets contains:
Olanzapine USP—5 mg Excipients–q.s In a flavoured base | |
| 35 | OLANZAPINE MOUTH DISSOLVING TABLETS
| Each uncoted mouth dissolving tablets contains:
Olanzapine USP—10 mg Excipients–q.s In a flavoured base | |
| 36 | PAROXETINE TABLETS USP 20 MG
| Each film coated tablet contains:
Paroxetine Hydrochloride USP eq. to Paroxetine—20 mg Excipients—q.s Colour: Approved colour used. | |
| 37 | LEVETIRACETAM TABLETS USP
| Each film cpated tablet contains:
Levetiracetam USP—500 mg Excipients–q.s Colour: Approved colour used | |
| 38 | SODIUM VALPORATE WITH VALPROIC ACID CONTROLLED RELEASE TABLETS 500MG | Each film coated controlled release tablet contains:
Sodium Valproate i.p—333 mg Valproic acid i.p— 145 mg (Both together corresponds to sodium valporate i.p 500 mg) Excipients–q.s Colour: Approved colour used. | |
| 39 | Amoxapine Tablets IP 50 mg | Each uncoated tablet contains:
Amoxapine IP—50 mg Excipients—q.s | |
| 40 | Amoxapine Tablets IP 100 mg | Each uncoated tablet contains:
Amoxapine IP—100 mg Excipients—q.s | |
| 41 | Aripiprazole Tablets IP 2.5 mg | Each uncoated tablet contains:
Aripiprazole IP—2.5 mg Excipients—q.s | |
| 42 | Aripiprazole Tablets IP 7.5 mg | Each uncoated tablet contains:
Aripiprazole IP—7.5 mg Excipients—q.s | |
| 43 | Ropinirole Tablets USP 4 mg | Each film coated tablet contains:
Ropinirole Hydrochloride USP eq. to Ropinirole—4 mg Excipients—q.s Colour: Approved colour used. | |
| 44 | Sodium Valporate & Valporic Acid Controlled Release Tablets 200 mg | Each film coated controlled release tablet contains:
Sodium Valproate i.p—134 mg Valproic Acid i.p— 58 mg (Both together corresponds to sodium valporate B.P 200 mg) Excipients–q.s Colour: Approved colour used. | |
| 45 | SODIUM VALPORATE & VALPORIC ACID CONTROLLED RELEASE TABLETS 200 MG | Each film coated controlled release tablet contains:
Sodium Valproate B.P—134 mg Valproic Acid B.P— 58 mg (Both together corresponds to sodium valporate B.P 200 mg) Excipients–q.s Colour: Approved colour used. | |
| 46 | DOTHIEPIN HYDROCHLORIDE TABLETS I.P | Each film coated tablet contains:
Dothiepin Hydrochloride I.P–75 mg Excipients–q.s Colour- Approved colour used | |
| 47 | ARIPIPRAZOLE TABLETS IP 10 MG | Each uncoated tablet contains:
Aripiprazole IP—10 mg Excipients—q.s | |
| 48 | ARIPIPRAZOLE TABLETS IP 15 MG | Each uncoated tablet contains:
Aripiprazole IP—15 mg Excipients—q.s | |
| 49 | OLANZAPINE TABLETS IP 20 MG | Each film coated tablet contains:
Olanzapine IP—20 mg Excipients—q.s | |
| 50 | DOTHIEPINE TABLETS IP 25 MG | Each film coated tablet contains:
Dothiepin Hydrochloride I.P–25 mg Excipients–q.s Colour- Approved colour used | |
| 51 | DIVALPOREX SODIUM EXTENDED RELEASE TABLETS IP 250 MG | Each film coated extended release tablets contains:
Divalporex Sodium IP eq. to Valporic Acid—500 mg Excipients—q.s Colour: Approved colour used. | |
| 52 | PAROXETINE PROLONGED-RELEASE TABLETS I.P | Each film coated tablet contains:
Paroxetine Hydrochloride USP eq. to Paroxetine—12.5 mg Excipients—q.s Colour: Approved colour used. | |
| 53 | TOPIRAMATE TABLETS IP | Each film coated tablet contains:
Topiramate IP—50 mg Excipients—q.s Colour: Approved colour used. | |
| 54 | OLANZAPINE TABLETS IP 20 MG | Each film coated tablet contains:
Olanzapine IP—20 mg Excipients—q.s Colour: Approved colour used. | |
| 55 | DOTHIEPINE TABLETS IP 25 MG | Each film cooated tablet contains:
Dothiepine Hydrochloride IP—25 mg Excipients—q.s Colour: Approved colour used. | |
| 56 | DULOXETINE GASTRO-RESISTANT TABLETS IP 30 MG | Each gastro resistant tablet contains:
Duloxetine Hydrochloride IP eq. to Duloxetine—30 mg Excipients—q.s Colour: Approved colour used | |
| 57 | ARIPIPRAZOLE TABLETS IP 10 MG | Each uncoated tablet contains:
Aripiprazole IP—10 mg Excipients—q.s | |
| 58 | ARIPIPRAZOLE TABLETS IP 15 MG | Each uncoated tablet contains:
Aripiprazole IP—15 mg Excipients—q.s | |
| 59 | OLANZAPINE TABLETS IP 10 MG | Each film coated tablet contains:
Olanzapine IP—10 mg Excipinets—q.s Colour: Approved colour used. | |
| 60 | SERTRALINE HYDROCHLORIDE TABLETS IP 25 MG | Each film coated tablet contains:
Sertraline Hydrochloride IP—25 mg Excipients—q.s Colour: Approved colour used. | |
| 61 | ARIPIPRAZOLE TABLETS IP | Each uncoated tablets contains:
Aripiprazole IP—5 mg Excipients—q.s | |
| 62 | CABERGOLINE TABLETS IP 0.25 MG | Each uncoated tablets contains:
Cabergoline IP—0.25 mg Excipients—q.s | |
| 63 | DULOXETINE GASTRO-RESISTANT TABLETS IP 20 MG | Each gastro-resistant talets contains:
Duloxetine HCl IP eq. to Duloxetine—20 mg Excipients—q.s Colour: Approved colour used. | |
| 64 | PIRACETAM AND CITICOLINE TABLETS
| Each film coated tablet contains:
Piracetam BP—800 mg Citicoline Sodium USP eq. to Citicoline—500 mg Excipients—q.s | |
| 65 | 
| Each film coqated talet conatins:
Escitalopram Oxalate IP eq. to Escitalopram—10 mg Excipients—q.s Colour: Approved colour used. | |
| 66 | ESCITALOPRAM TABLET IP 20 MG | Each film coqated talet conatins:
Escitalopram Oxalate IP eq. to Escitalopram—20 mg Excipients—q.s Colour: Approved colour used. | |
| 67 | FLUPENTIXOL 0.5 MG & MELITRACEN TABLETS 10 MG | Each film coated tablet contains :
Flupentixol Hydrochloride B.P. Eq. to Flupentixol— 0.5 mg Melitracen Hydrochloride Eq. to Melitracen—10 mg Excipient—q.s. Colour : Approved colour used in tablet | |
| 68 | TOPIRAMATE TABLETS IP 100 MG | Each film coated tablet contains:
Topiramate IP—100 mg Excipients—q.s Colour: Approved colour used. | |
| 69 | PRAMIPEXOLE DIHYDROCHLORIDE TABLETS 0.125 MG | Each uncoated tablet contains:
Pramipexole Dihydrochloride Monohydrate BP—0.125 mg Excipients—-q.s Colour: Approved colour used. | |
| 70 | 
| Each uncoated tablet contains:
Pramipexole Dihydrochloride Monohydrate BP—0.25 mg Excipients—-q.s Colour: Approved colour used. | |
| 71 | PRAMIPEXOLE DIHYDROCHLORIDE TABLETS 0.5 MG | Each uncoated tablet contains:
Pramipexole Dihydrochloride Monohydrate BP—0.5 mg Excipients—-q.s Colour: Approved colour used. | |
| 72 | MEMANTINE HYDROCHLORIDE TABLETS IP 5 MG | Each film coated tablet contains:
Memantine Hydrochloride IP—5 mg Excipients—q,s Colour: Approved colour used. | |
| PROTEIN SUPPEMENT | ||
| S. No. | Generic Name | Composition |
| 1 | L-GLUTAMINE DISPERSIBLE TABLET 1000 MG | Each uncoated tablet contains: L-Glutamine u.s.p—1000 mg Excipients–q.s |
| ANTI-VIRAL | |||
| S. No. | Generic Name | Composition | |
| S.No. | Generic Name | Composition | |
| 1 | VALGANCICLOVIR TABLETS USP 450 MG | Each film coated tablet contains:
Valganciclovir Hydrochloride usp eq. to valganciclovir—450 mg Excipients–q.s Colour: Ferric oxide red usp-nf & titanium dioxide ip | |
| 2 | VALACYCLOVIR TABLETS USP 1000 MG | Each film coated tablet contains:
Valacyclovir Hydrochloride USP eq. to Valacyclovir—1000 mg Excipients–q.s Colour: Approved colour used. | |
| 3 | VALACYCLOVIR TABLETS USP 500 MG | Each film coated tablet contains:
Valacyclovir Hydrochloride USP eq. to Valacyclovir—500 mg Excipients–q.s Colour: Approved colour used. | |
| 4 | FAVIPIRAVIR TABLETS 200 MG
| Each film coated tablet contains:
Favipiravir —200 mg Excipients—q.s Colour: Approved colour used. | |
| 5 | FAVIPIRAVIR TABLETS 400 MG
| Each film coated tablet contains:
Favipiravir —400 mg Excipients—q.s Colour: Approved colour used. | |
| 6 | ENTECAVIR TABLETS IP 0.5 MG | Each film coated tablet contains:
Entecavir IP—0.5 mg Excipients—q.s Colour: Approved colour used. | |
| 7 | TENOFOVIR ALAFENAMIDE 25 MG TABLET | Each film coated tablet contains:
Tenofovir Alafedamide Hemifumarate eq. to Tenofovir Alafenamide—25 mg Excipients—q.s Colour: Approved colour used. | |
| 8 | SOFOSBUVIR TABLETS 400 MG | Each film coated tablet contains:
Sofosbuvir—400 mg Excipients—q.s Colour: Approved colour used. | |
| 9 | ACICLOVIR TABLETS IP 200 MG | Each uncoated tablet contains:
Aciclovir IP—200 mg Excipients—q.s | |
| 10 | TENOFOVIR DISOPROXIL FUMARATE TABLETS IP 300 MG | Each film coated tablet contains:
Tenofovir Disoproxil Fumrate IP—300 mg Excipients–q.s Colour: Approved colour used. | |
| 11 | SOFOSBUVIR TABLETS 400 MG | Each film coated tablet contains:
Sofosbuvir—400 mg Excipients—q.s Colour: Approved colour used. | |
| 12 | 
| Each film coated tablet contains:
Tenofovir Disoproxil Fumrate IP—300 mg Excipients–q.s Colour: Approved colour used. | |
| 13 | TENOFOVIR ALAFENAMIDE 25 MG TABLET | Each film coated tablet contains:
Tenofovir Alafedamide Hemifumarate eq. to Tenofovir Alafenamide—25 mg Excipients—q.s Colour: Approved colour used. | |
| 14 | ACICLOVIR TABLETS IP 400 MG | Each uncoated tablet contains:
Aciclovir IP—400 mg Excipients—q.s | |
| 15 | 
| Each uncoated tablet contains:
Aciclovir IP—200 mg Excipients—q.s | |
| 16 | ACICLOVIR TABLETS IP 400 MG | Each uncoated tablet contains:
Aciclovir IP—400 mg Excipients—q.s | |
| ANTIBILE | ||
| S. No. | Generic Name | Composition |
| 1 | Each uncoated tablet contains:
Ursodeoxycholic acid i.p—150 mg Excipients–q.s | |
| 2 | URSODEOXYCHOLIC ACID TABLETS I.P 300 MG | Each uncoated tablet contains:
Ursodeoxycholic acid i.p—300 mg Excipients–q.s |
| AMINO ACID SUPPLEMENT | ||
| S. No. | Generic Name | Composition |
| 1 | ESSENTIAL AMINO ACID TABLETS | Each fim coated tablet contains:
L-Histadine u.s.p—45 mg L-isoleucine b.p—60 mg L-lrucine b.p—90 mg L-Lysine hydrochloride u.s.p.—65 mg L-Methionine b.p—90 mg L-Phenylalanine b.p—70 mg L-Threonine u.s.p—65 mg L-Tryptophan u.s.p.—25 mg L-Tyrosine u.s.p—75 mg L-Valine b.p—135 mg Toal Amino acid—720 mg Nitrogen—88 mg Correspoding to proteine—0.55 g Excipients–q.s Colour: Titanium dioxide i.p |
| 2 | L-ORNITHINE L-ASPARATE & PANCREATIN TABLETS | Each enteric coated tablet contains:
L-Ornithine L-Aspartate—150 mg Pancreatin i.p—100 mg Excipients—q.s Colour:- Approved Colours Used. |
| ANTI EMETIC | ||
| S. No. | Generic Name | Composition |
| 1 | ONDANSETRON ORALLY DISINTEGRATING TABLETS I.P 4 MG | Each uncoated orally disintegrating tablet contains:
Ondansetron Hydrochloride i.p—4 mg Excipients—q.s Colour: Sunset yellow fcf |
| 2 | ONDANSETRON ORALLY DISINTEGRATING TABLETS I.P 8 MG | Each uncoated orally disintegrating tablet contains:
Ondansetron Hydrochloride I.P eq. to Ondansetron—8 mg Excipients—q.s Colour: Approved colour used. |
| 3 | GRANISETRON HYDROCHLORIDE 1 MG TABLET | Each uncoated dispersible tablet contains:
Granisetron Hydrochloride eq. to Granisetron—1 mg Excipients—q.s |
| ANTIFUNGAL | ||
| S. No. | Generic Name | Composition |
| 1 | TERBINAFINE TABLETS I.P 250 MG | Each uncoated tablet contains:
Terbinafine Hydrochloride i.p eq. to Terbinafine—250 mg Excipients–q.s |
| 2 | VORICONAZOLE TABLETS I.P 200 MG | Each film coated tablet contains:
Variconazole i.p– 200 mg Excipients–q.s |
| 3 | GRISEOFULVIN TABLETS I.P 500MG | Each uncoated tablet contains :
Griseofulvin I.P. 500 mg Excipient q.s. |
| 4 | TERBINAFINE HYDROCHLORIDE TABLETS USP
| Each uncoated tablet contains:
Terbinafine Hydrochloride USP eq. to Terbinafine—250 mg Excipients–q.s |
| 5 | VORICONAZOLE TABLETS I.P 200 MG | Each film coated tablet contains:
Voriconazole I.P—200 mg Excipients—q.s Colour: Approved colour used. |
| THYROXIN AGENT | ||
| S. No. | Generic Name | Composition |
| 1 | Thyroxine Sodium Tablets IP 25 mcg | Each uncoated tablet contains:
Thyroxine Sodium IP eq. to Anhydrous Thyroxine Sodium—25 mcg Excipients—q.s |
| 2 | Thyroxine Sodium Tablets IP 75 mcg | Each uncoated tablet contains:
Thyroxine Sodium IP eq. to Anhydrous Thyroxine Sodium—75 mcg Excipients—q.s |
| 3 | LIOTHYRONINE SODIUM TABLETS USP
| Each film coate dtablet contains:
Liothyronine Sodium eq. to Liothyronine—5 mcg Excipients—q.s Colour: Approved colour used. |
| 4 | LIOTHYRONINE SODIUM TABLETS USP
| Each film coate dtablet contains:
Liothyronine Sodium eq. to Liothyronine—25 mcg Excipients—q.s Colour: Approved colour used. |
| GASTROINTESTINAL | ||
| S. No. | Generic Name | Composition |
| 1 | Mesalazine Prolonged release Tablets IP 500 mg | Each film coated prolonged release tablet contains:
Mesalazine IP—500 mg Excipients—q.s Colour: Approved colour used. |
| 2 | Mesalazine Delayed release Tablets IP 800 mg | Each film coated delayed release tablet contains:
Mesalazine IP—800 mg Excipients—q.s Colour: Approved colour used. |
| CALCIUM SUPPLEMENT & ORTHOPAEDICS | ||
| S. No. | Generic Name | Composition |
| 1 | CALCIUM CITRATE, CALCITRIOL WITH ZINC TABLET | Each film coated tablet contains:
Calcium Citrate usp— 1000 mg Calcitriol i.p—0.25 mcg Magnesium Hydroxide i.p— 100 mg Zinc Sulphate Monohydrate i.p eq. to elemental zinc—7.5 mg Exipients–q.s Colour: Titanium dioxide i.p Appropriate overages of vitamins added to compensate for loss |
| 2 | CALCIUM CITRATE,VITAMIN D3, MAGNESIUM HYDROXIDE & ZINC TABLETS | Each film coated tablet contains:
Calcium Citrate usp— 1000 mg Vitamin D3 i.p—200 iu Magnesium Hydroxide i.p— 100 mg Zinc Sulphate Monohydrate i.p eq. to elemental zinc—4 mg Exipients–q.s Colour: Titanium dioxide i.p Appropriate overages of vitamins added to compensate for loss |
| 3 | CALCIUM CARBONATE & CALCITIOL TABLETS | Each film coated tablet contains:
1.25 g of calcium carbonate i.p from an organic source (oyster shell) eq. to elemental calcium–500 mg Calcitriol i.p—0.25 mcg Excipients–q.s Colour: Titanium dioxide i.p Appropriate overages of vitamin added to compensate for loss on |
| 4 | CALCIUM CARBONATE, ALPHA LIOPIC ACID, BENFOTIAMINE, INOSITOL, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, METHYLCOBALAMIN, CHROMIUM PICOLINATE & CALCITRIOL TABLETS | Each film coated tablet contains:
Calcium carbonate i.p—500 mg Alpha Liopic Acid usp— 200 mg Benfotiamine b.p—150 mg Inositol usp—100mg Pyridoxine Hydrochloride i.p—3 mg Folic Acid i.p— 1.5 mg Methylcobalamin i.p–1500 mcg Chromium Picolinate usp—200 mcg Calcitriol i.p—0.25 mg Exipients–q.s Colour: Ferric oxide red usp-nf & titanium dioxide i.p Appropriate overages of vitamins added to compensate for loss Colour: Approved colour used |
| 5 | CALCIUM & VITAMIN D3 TABLET I.P (500 MG+200 I.U) | Each film coated tablet contains:
1.25 g of calcium carbonate i.p from an organic source (oyster shell) eq. to elemental calcium–500 mg Vitamin D3 i.p—200 i.u Excipients–q.s Colour: Lake of brilliant blue fcf & titanium dioxide i.p Appropriate overages of vitamin added to compensate for loss on |
| 6 | CALCIUM & VITAMIN D3 TABLET I.P (500 MG+250 I.U) | Each film coated tablet contains:
1.25 g of calcium carbonate i.p from an organic source (oyster shell) eq. to elemental calcium–500 mg Vitamin D3 i.p—250 i.u Excipients–q.s Colour: Lake of brilliant blue fcf & titanium dioxide i.p Appropriate overages of vitamin added to compensate for loss on |
| 7 | CALCIUM & VITAMIN D3 TABLET I.P (500 MG+500 I.U) | Each film coated tablet contains:
1.25 g of calcium carbonate i.p from an organic source (oyster shell) eq. to elemental calcium–500 mg Vitamin D3 i.p—500 i.u Excipients–q.s Colour: Lake of brilliant blue fcf & titanium dioxide i.p Appropriate overages of vitamin added to compensate for loss on |
| 8 | CALCITRIOL TABLETS 0.25 MCG | Each film coated tablet contains:
Calcitriol i.p—0.25 mcg Excipients—q.s Colour: Titanium dioxide i.p |
| 9 | CALCIUM CARBONATE TABLETS I.P 500 MG | Each film coated tablet contains:
1.25 g of calcium carbonate i.p from an organic source (oyster shell) eq. to elemental calcium–500 mg Excipients–q.s Colour: Lake of brilliant blue fcf & titanium dioxide i.p |
| 10 | CALCIUM CITRATE MALATE, CHOLECALCIFEROL & FOLIC ACID TABLETS | Each film coated tablet contains:
Calcium citrate malate eq. to elemental calcium—250 mg Cholecalciferol i.p—100 iu folic acid i.p—50 mcg Excipients–q.s Colour: Titanium dioxide i.p |
| 11 | CALCIUM CITRATE, MAGNESIUM HYDROXIDE, ZINC SULPHATE & VITAMIN D3 TABLETS (1000mg+100mg+4mg+1000iu) | Each film coated tablet contains:
Calcium Citrate usp— 1000 mg Magnesium Hydroxide i.p— 100 mg Zinc Sulphate Monohydrate i.p eq. to elemental zinc—4 mg Vitamin D3 i.p—1000 iu Exipients–q.s Colour: Approved colour used |
| 12 | CALCIUM CITRATE, MAGNESIUM HYDROXIDE, ZINC SULPHATE & VITAMIN D3 TABLETS (1000mg+100mg+4mg+200iu) | Each film coated tablet contains:
Calcium Citrate usp— 1000 mg Magnesium Hydroxide i.p— 100 mg Zinc Sulphate Monohydrate i.p eq. to elemental zinc—4 mg Vitamin D3 i.p—200 iu Exipients–q.s Colour: Approved colour used |
| 13 | CALCIUM ACETATE TABLET USP | Each film coated tablet contains:
Calcium Acetate u.s.p—667 mg Excipients—q.s Colour: Approved Colours Used |
| 14 | CALCIUM CARBONATE & CHOLECALCIFEROL BP TABLET
| Each film coated tablet contains:
Calcium carbonate B.P. (as Oyster shell) eq. to Elemental calcium—200 mg Cholecalciferol B.P—500 I.U Excipients: q.s Colour: Titanium Dioxide B.P |
| 15 | CALCIUM, VITAMIN D3, METHYLCOBALAMIN, L-METHYLFOLATE CALCIUM & PYRIDOXAL-5-PHOSPHATE TABLETS | Each film coated tablet contains:
Calcium carbonate I.P—1250 mg eq. to Elemental Calcium—500 mg Vitamin D3 I.P—2000 I.U Mecobalamin I.P—1500 mcg (Methylcobalamin) L-Methylfolate Calcium—1 mg Pyridoxal-5-Phosphate—20 mg Excipients—q.s Colour: Approved colour used. |
| 16 | CALCIUM & VITAMIN D3 TABLETS IP | Each film coated tablet contains:
Calcium carbonate I.P (from coral grains) eq. to Elemental Calcium—500 mg Vitamin D3 I.P (as stabilized granules)—200 I.U Excipients—q.s Colour: Approved colour used Appropriate overages of vitamin added. |
| 17 | CALCIUM & VITAMIN D3 TABLETS IP | Each film coated tablet contains:
1.25 g of calcium carbonate ip from an organic source (as eq. to Elemental Calcium—500 mg Vitamin D3 I.P—500 I.U Excipients—q.s Colour: Approved colour used Appropriate overages of vitamin added to compensate for loss on |
| 18 | CALCIUM, VITAMIN D3, METHYLCCOBALAMIN, L-METHYLFOLATE CALCIUM & AMP: PYRIDOXAL-5 PHOSPHATE TABLETS | Each film coated tablet contains:
Calcium carbonate I.P—1250 mg eq. to Elemental Calcium—500 mg Vitamin D3 I.P—2000 I.U Mecobalamin I.P—1500 mcg (Methylcobalamin) L-Methylfolate Calcium—1 mg Pyridoxal-5-Phosphate—20 mg Excipients—q.s Colour:Approved colour used. Appropriate overages of vitamins added to comensate the loss on |
| 19 | CALCIUM ACETATE TABLET USP | Each film coated tablet contains:
Calcium Acetate U.S.P—667 mg Excipients—q.s Colour: Approved Colours Used |
| 20 | CALCIUM CITRATE, VITAMIN D3 & ZINC TABLET | Each filmc oated tablet contains:
Calcium Citrate USP—1000 mg Vitamin D3 IP—200 IU Zinc Sulphate Monohydrate IP eq. to Elemental Zinc—4 mg Excipients—q,s colour: Approved colour used. |
| MULTIVITAMIN & HAEMTINICS | ||
| S. No. | Generic Name | Composition |
| 1 | FOLIC ACID, METHYLCOBALAMIN, BIOTIN, CALCIUM PANTOTHENATE & VITAMINS TABLETS | Each film coated tablet contains:
Niacinamide i.p—20 mg Folic acid i.p—10 mg Pyridoxine hydrochloride i.p—10 mg Calcium Pantothenate i.p—5 mg Riboflavin i.p—1.5 mg Thiamine mononitrate i.p—1.5 mg Methylcobalamin i.p—500 mcg Biotin u.s.p—300 mcg Excipients–q.s Colour: Ferric oxide red usp-nf & titanium dioxide i.p Appropriate overages of vitamins added to compensate for loss |
| 2 | LYCOPENE, LUTEIN, BETA CAROTENE, VITAMIN D3. B6, B12, NIACINAMIDE, FOLIC ACID, BIOTINE, FERROUS FUMARATE, LYSINE & MULTIMINERAL TABLETS | Each film coated tablet contains:
Lycopene usp 6 %— 5 mg Lutein usp 8 %—6 mg Beta carotene usp (10 % dispersion)— 10mg Vitamin D3 i.p—200 i.u Vitamin B6 i.p— 1 mg Vitamin B12 i.p—0.5 mcg Niacinamide i.p—25 mg Folic Acid i.p— 300 mcg Biotin usp—25 mcg Ferrous fumarate i.p—45 mg Lysine hydrochloride i.p— 50 mg Dibasic calcium phosphate i.p—75 mg Chromium chloride usp—200 mcg Copper sulfate pentahydrate bp eq. to copper sulfate—500 mcg Magnesium Hydrochloride i.p—10 mg Manganese sulfate monohydrate b.p eq. to manganese sulphate—600 mcg Sodium selenite pentahydrate bp eq. to sodium selenite—100 Zinc sulfate monohydrate i.p eq. to zinc sulphate—10 mg Excipients–q.s Colour: Ferric oxide red usp-nf & titanium dioxide i.p Appropriate overages of vitamins added to compensate for loss |
| 3 | FERROUS ASCORBATE, FOLIC ACID, METHYLCOBALAMIN, BIOTIN, CALCIUM PANTOTHENATE & MULTIVITAMIN TABLETS | Each film coated tablet contains:
Ferrous ascorbate eq. to elemental iron—100 mg Folic acid i.p—10 mg Methylcobalamin i.p—500 mcg Biotin u.s.p—300 mcg Calcium Pantothenate i.p—6 mg Vitamin B1 i.p—2 mg Vitamin B2 i.p—3 mg Vitamin B3 i.p—25 mg Vitamin B6 i.p—10 mg Excipients–q.s Colour: Ferric oxide red usp-nf & titanium dioxide i.p Appropriate overages of vitamins added to compensate for loss |
| 4 | FERROUS ASCORBATE, FOLIC ACID, VITAMIN B12 & ZINC TABLETS | Each film coated tablet contains:
Ferrous ascorbate eq. to elemental iron—100 mg Folic acid i.p—1.5 mg Vitamin B12 i.p—15 mcg Zinc sulphate monohydrate i.p eq. to elemental zinc—22.5 mg Excipients–q.s Colour: Ferric oxide red usp-nf & titanium dioxide i.p Appropriate overages of vitamins added to compensate for loss |
| 5 | METHYLCOBALAMIN & BIOTIN WITH ESSENTIAL VITAMINS TABLETS | Each film coated tablet contains:
Ascorbic acid i.p—60 mg Niacinamide i.p—20 mg Pyridoxine Hydrochloride i.p—20 mg Folic Acid i.p— 10 mg Pantothenate acid—10 mg (Calcium Pantothenate i.p) Riboflavin i.p—3 mg Thiamine hydrochloride i.p—2 mg Methylcobalamin i.p—1500 mcg Biotin u.s.p.—300 mcg Excipients–q.s Colour: Ferric oxide red usp-nf ferric oxide black usp-nf & Appropriate overages of vitamin added to compensate for loss on |
| 6 | CHOLECALCIFEROL CHEWABLE TABLETS 60,000 I.U | Each uncoated tablet contains:
Cholecalciferol i.p— 60,000 i.u (As stabilized form) Excipients–q.s Colour: Sunset yellow fcf Appropriate overages of vitamin added to compensate for loss on |
| 7 | VITAMINS & MULTIMINERAL TABLETS | Each film coated tablet contains:
Thiamine monohydrate i.p—300 mg Pyridoxine hydrochloride i.p—50 mg Folic acid I.p—1.5 mg Light magnesium oxide i.p—375 mg Copper sulphate pentahydrate b.p eq. to cooper sulphate—2 mg Sodium selenite pentahydrate b.p eq. to sodium selenite—200 Zinc sulphate monohydrate i.p eq. to zinc sulphate—50 mg Excipients–q.s Colour: Ferric oxide red usp-nf & titanium dioxide i.p Appropriate overages of vitamin added to compensate for loss on |
| 8 | FERROUS ASCOTBATE & FOLIC ACID TABLETS | Each film coated tablet contains:
Ferrous ascorbate eq. to elemental iron—100 mg Folic acid i.p—1.5 mg Excipients–q.s Colour: Ferric oxide red usp-nf & titanium dioxide i.p |
| 9 | FERROUS FUMARATE, ASCORBIC ACID, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CALCIUM PANTOTHENATE, RIBOFLAVIN, THIAMINE HYDROCHLORIDE, METHYLCOBALAMIN & BIOTIN TABLETS | Each film coated tablet contains:
Ferrous fumarate i.p eq. to elemental iron—200 mg Ascorbic acid i.p—50 mg Niacinamide i.p—25 mg Pyridoxine Hydrochloride i.p—10 mg Folic Acid i.p— 10 mg Calcium Pantothenate i.p—6 mg Riboflavin i.p—3 mg Thiamine hydrochloride i.p—2 mg Methylcobalamin i.p—500 mcg Biotin u.s.p.—300 mcg Excipients–q.s Colour: Ferric oxide red usp-nf & titanium dioxide i.p |
| 10 | FERRIC CITRATE TABLETS | Each film coated tablet contains:
Ferric citrate eq. to elemental iron–210 mg Excipients–q.s Colour: Ferric oxide red usp-nf & titanium dioxide i.p |
| 11 | VITAMIN C, ZINC & SELENIUM CHEWABLE TABLETS | Each uncoated chewable tablet contains:
Ascorbic acid i.p (Vit. C) — 500 mg Zinc sulphate monohydrate i.p eq. to elemental zinc– 22.5mg Sodium selenite usp eq. to elemental selenium–40 mcg Excipients–q.s Appropriate overages of vitamins added to compensate for loss |
| 12 | VITAMIN C, VITAMIN D3, ZINC & SELENIUM CHEWABLE TABLETS | Each uncoated chewable tablet contains:
Ascorbic acid i.p (Vit. C) — 500 mg Vitamin D3 i.p—2000 i.u Zinc sulphate monohydrate i.p eq. to elemental zinc—35mg Sodium selenite usp eq. to elemental selenium—40 mcg Excipients–q.s Approved colour used Appropriate overages of vitamins added to compensate for loss |
| 13 | METHYLCOBALAMIN, ALPHA LIOPIC ACID, THIAMINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE & FOLIC ACID TABLETS | Each film coated tablet contains:
Methylcobalamin i.p–1500 mcg Alpha Liopic Acid usp— 100 mg Thiamine Hydrochloride i.p— 10 mg Pyridoxine Hydrochloride i.p—3 mg Folic Acid i.p— 1.5 mg Exipients–q.s Colour: Approved colour used |
| 14 | FERROUS ASCORBATE, FOLIC ACID & ZINC SULPHATE TABLETS | Each film coated tablet contains:
Ferrous Ascorbate eq. to elemental iron— 100mg Folic Acid i.p—1.5 mg Zinc Sulphate Monohydrate i.p eq. to elemental zinc—22.5 mg Excipients: q.s Colour: Approved colour used |
| 15 | FERROUS ASCORBATE, FOLIC ACID, METHYLCOBALAMIN, BIOTIN, CALCIUM PANTOTHENATE, VITAMIN B1, VITAMIN B2, VITAMIN B3, VITAMIN B6 TABLETS | Each Film Coated Tablet Contains:
Ferrous Ascorbate eq. to elemental iron— 100mg Folic Acid i.p—10 mg Methylcobalamin I.P– 500 mcg Biotin U.S.P– 300 mcg Calcium Pantothenate I.P— 6 mg Vitamin B1 I.P— 2 mg Vitamin B2 I.P— 3 mg Vitamin B3 I.P— 25 mg Vitamin B6 I.P— 10 mg Excipients: q.s |
| 16 | FERROUS ASCORABATE, FOLIC ACID, METHYLCOBALAMIN, BIOTIN & MULTIVITAMINS | Each film coated tablet contains:
Ferrous Ascorbate eq. to Elemental Iron—100 mg Folic Acid B.P—10 mg Methylcobalamin—500 mcg Biotin USP—300 mcg Calcium Pantothenate B.P—6 mg Vitamin B1 Mononitrate B.P—2 mg Vitamin B2 B.P—3 mg Vitamin B3 B.P—25 mg Vitamin B6 B.P—10 mg Excipients: q.s Colour: Red oxide of iron & Titanium dioxided USP |
| 17 | FERROUS ASCORBATE, FOLIC ACID, METHYLCOBALAMIN, BIOTIIN, CALCIUM, PANTOTHENATE & MULTIVITAMIN TABLETS | Each film coated tablet contains:
Ferrous ascorbate eq. to elemental iron—100 mg Folic Acid I.P—1.5 mg Methylcobalamin I.P—500 mcg Biotin USP—300 mcg Calcium Pantothenate I.P—6 mg Vitamin B1 I.P–2mg Vitamin B2 I.P—3 mg Vitamin B3 I.P—25 mg Vitamin B6 I.P—10 mg Excipients—q.s Colour: Approved colour used. |
| 18 | FERROUS ASCORBATE & L-METHYLFOLATE CALCIUM TABLETS | Each Film coated tablet contains:
Ferrous Ascorbate eq. to Elemental Iron—100 mg L-Methyl folate calcium eq. to L-Methyl folate—0.5 mg Excipients–q.s Colour: Approved colour used. |
| 19 | METHYLCOBALAMIN, ALPHA LIOPIC ACID, FOLIC ACID, PYRIDOXINE HCL & VITAMIN D3 TABLETS | Each film coated tablet contains:
Methylcobalamin—1500 mcg Alpha Liopic Acid—100 mg Folic Acid—5 mg Pyridoxine HCl—3 mg Vitamin D3—2000 IU Excipients–q.s colour: Approved colour used. |
| 20 | METHYLCOBALAMIN, ALPHA LIOPIC ACID, FOLIC ACID, PYRIDOXINE HYDROCHLORIDE & VITAMIN D3 TABLETS | Each tablet contains:
Methylcoblamin 1500mcg Alpha Lipoic Acid 100mg Folic Acid 1.5 mg Pyridoxine Hydrochloride 3mg Vitamin D3 1000iu Excipients—q.s |
| 21 | RIBOFLAVIN, FOLIC ACID, NIACINAMIDE & LACTIC ACID BACILLUS SPORES TABLETS | Each uncoated tablet contais:
Riboflavin I.P—10 mg Folic Acid I.p—1.5mg Niacinamide I.p—100 mg Lactic Acid Bacillus—60 million spores Excipients—q.s |
| 22 | ASCORBIC ACID TABLET IP 500 MG | Each uncoated tablet contains:
Ascorbic Acid I.P—500 mg Excipients—q.s |
| 23 | ASCORBIC ACID CHEWABLE TABLET IP 500 MG | Each uncoated chewable tablet contains:
Ascorbic Acid I.P—500 mg Excipients—q.s Colour: Approved colour used. |
| 24 | METHYLCOBALAMIN, L-METHYLFOLATE CALCIUM & PYRIDOXAL-5-PHOSPHATE | Each film coated tablet contains:
Methylcobalamin IP—1500 mcg L-Methylfolate Calcium—1 mg Pyridoxal-5-Phosphate—0.5 mg Excipients—q.s Colour: Approved colour used |
| 25 | ASCORBIC ACID TABLETS IP 500 MG | Each uncoated tablet contains:
Ascorbic Acid I.P—500 mg Excipients—q.s |
| 26 | FERROUS ASCORBATE & FOLIC ACID TABLETS | Each film coated tablet contains:
Ferrous Ascorbate eq. to elemental iron—100 mg Folic Acid IP—1.5 mg Excipients—q.s Colour: Approved colour used. |
| 27 | METHYLCOBALAMIN, BENFOTIAMINE, ALPHA LIOPIC ACID, FOLIC ACID, CHROMIUM PICOLNATE, INOSITOL & PYRIDOXINE HYDROCHLORIDE TABLETS | Each film coated tablet contains:
Methylcobalamin I.P—1500 mcg Benfotiamine B.P—200 mg Alpha Liopic Acid U.S.P—200 mg Folic Acid I.P—1.5 mg Chromium Picolinate U.S.P—200 mcg Insoitol—10 mg Pyridoxine Hydrochloride I.P—20 mg Excipients—q.s Colour: Approved colour used. |
| 28 | METHYLCOBALAMIN, ALPHA LIOPIC ACID, FOLIC ACID, PYRIDOXINE HCL & VITAMIN D3 TABLETS | Each film coated tablet contains:
Methylcobalamin IP—1500 mcg Alpha Liopic Acid USP—100 mg Folic Acid IP—5 mg Pyridoxine HCl IP—3 mg Vitamin D3 IP—2000 IU Excipients—q.s Colour: Approved colour used. Appropriate overages of vitamins are added to compensate any |
| 29 | FERROUS ASCORBATE, FOLIC ACID, & VITAMIN C TABLETS | Each film coated tablet contains:
Ferrous fumarate IP eq. to Elemental Iron—100 mg Folic Acid IP—1.5 mcg Ascorbic Acid IP (Vit. C)—250 mg Excipients—q.s Colour: Approved colour used. Appropriate overages of vitamins are added to compensate any |
| 30 | FOLIC ACID & VITAMIN B12 TABLET | Each film coated tablet contains:
Folic Acid IP—5 mg Vitamin B12 IP—1500 mcg Excipients—q.s Colour: Approved colour used. Appropriate overages of vitamins are added to compensate any |
| 31 | FERROUS ASCORBATE, FOLIC ACID & VITAMIN C TABLETS | Each film coated tablet contains:
Ferrous Ascorbate IP eq. to Elemental Iron—100 mg Folic Acid IP—1.5 mcg Ascorbic Acid IP (Vit. C)—205 mg Excipients—q.s Colour: Approved colour sued Appropriate overages added to compensate for loss on storage. |
| 32 | FOLIC ACID & VITAMIN B12 SUBLINGUAL TABLET | Each uncoated sublingual tablet contains:
Folic Acid IP—5 mg Vitamin B12 IP—1500 mcg Excipients—q.s Colour: Approved colour used Appropriate overages added to compensate for loss on storage. |
| 33 | POTASSIUM MAGNESIUM CITRATE & VITAMIN B6 TABLETS | Each film coated tablet contains:
Potassium magnesium citrate—978 mg Vitamin B6 i.p— 15 mg Excipients–q.s Colour: Lake of sunset yellow fcf & titanium dioxide i.p Appropriate overages of vitamins addedt to compensate for loss |
| 34 | N-ACETYLCYSTEINE & PYRIDOXAMINE DIHYDROCHLORIDE TABLETS | Each film coated tablet contains:
N-acetylcysteine u.s.p—300 mg Pyridoxamine dihydrochloride—75 mg Excipients–q.s Colour: Lake of ponceau-4r & titanium dioxide i.p |
| 35 | BIOTIN, INOSITOL, NIACINAMIDE, CALCIUM, PANTOTHENATE, IRON, MINERALS & AMINO ACIDS TABLETS | Each film coated tablet contains:
Biotin b.p—10 mg Inositol usp—10mg Niacinamide i.p—50 mg Calcium pantothenate i.p—100 mg Ferrous fumarate i.p eq. to Elemental iron—10 mg Copper sulphate pentahydrate b.p eq. to elemental elemental copper—2 mg Sodium selenite pentahydrate b.p eq. to elemental selenium— Zinc sulphate monohydrate i.p eq. to elemental zinc—25 mg L-Lysine hydrochloride usp—20 mg L-Cysteine hydrochloride monohydrate b.p eq. to elemental l-cysteine—50 mg L-arginine i.p—50 mg DL-Methionine b.p—40mg Para amino benzoic acid b.p—100 mg Excipients—q.s Colour: Ferric oxide red usp-nf & titanium dioxide i.p Appropriate overages of vitamins added to compensate for loss |
| 36 | ALPHA KETOANALOGUE TABLETS | Each film coated tablet contains :
Calcium -3-methyl-2-oxo-valerate —67 mg (α-ketoanalogue to isoleucine, Calcium salt) Calcium-4-methyl-2-oxo-valerate—101 mg (α-ketoanalogue to leucine, Calcium salt) Calcium-2-oxo-3-phenylpropionate—68 mg (α-ketoanalogue to phenylalanine, Calcium salt) Calcium -3-methyl-2-oxo-butyrate— 86 mg (α-ketoanalogue to valine, Calcium salt) Calcium –DL-2-Hydroxy -4(Methylthio) Butyrate—59 mg (α-hydroxyanalogue to methionine, Calcium salt) L-Lysine Acetate U.S.P.— 105 mg (Eq. to L-Lysine 75 mg) L-Threonine U.S.P.—53 mg L-Tryptophan U.S.P—23 mg L- Histidine U.S.P.—38 mg L-Tyrosine U.S.P. —30 mg Total nitrogen content per tablet —36 mg Calcium content per tablet —1.25 mmol=0.05 g Excipients —q.s. Colour : Titanium Dioxide I.P. Appropriate overages added to compensate for loss on storages |
| 37 | ALPHA KETOANALOGUE TABLETS | Each film coated tablet contains :
Calcium -3-methyl-2-oxo-valerate —67 mg (α-ketoanalogue to isoleucine, Calcium salt) Calcium-4-methyl-2-oxo-valerate—101 mg (α-ketoanalogue to leucine, Calcium salt) Calcium-2-oxo-3-phenylpropionate—68 mg (α-ketoanalogue to phenylalanine, Calcium salt) Calcium -3-methyl-2-oxo-butyrate— 86 mg (α-ketoanalogue to valine, Calcium salt) Calcium –Dl-2-Hydroxy -4(Methylthio) Butyrate—59 mg (α-hydroxyanalogue to methionine, Calcium salt) L-Lysine Acetate U.S.P.— 105 mg (Eq. to L-Lysine 75 mg) L-Threonine U.S.P.—53 mg L-Tryptophan U.S.P—23 mg L- Histidine U.S.P.—38 mg L-Tyrosine U.S.P. —30 mg Total nitrogen content per tablet —36 mg Calcium content per tablet —1.25 mmol=0.05 g Excipients —q.s. Colour : Titanium Dioxide I.P. Appropriate overages added to compensate for loss on storages |
| 38 | BIOTIN WITH CALCIUM PANTOTHENATE, N-ACETYLCYSTEINE, L-METHIONINE, FOLIC ACID & MINERALS TABLETS | Each fim coated tablet contains:
Biotin b.p—10 mg Calcium Pantothenate i.p—30 mg N-acetylcysteine u.s.p.—150 mg L-methionine u.s.p—50 mg Folic Acid i.p—400 mcg Sodium selenite u.s.p. eq. to elemental selenium—100 mcg Cupric oxide eq. to elemetal copper—3 mg Zinc sulphate monohydrate i.p eq. to zinc sulphate—20 mg Excipients–q.s Colour: Carmoisine |
| 39 | ALPHA KETOANALOGUE TABLETS | Each film coated tablet contains :
Calcium -3-methyl-2-oxo-valerate —67 mg (α-ketoanalogue to isoleucine, Calcium salt) Calcium-4-methyl-2-oxo-valerate—101 mg (α-ketoanalogue to leucine, Calcium salt) Calcium-2-oxo-3-phenylpropionate—68 mg (α-ketoanalogue to phenylalanine, Calcium salt) Calcium -3-methyl-2-oxo-butyrate— 86 mg (α-ketoanalogue to valine, Calcium salt) Calcium –Dl-2-Hydroxy -4(Methylthio) Butyrate—59 mg (α-hydroxyanalogue to methionine, Calcium salt) L-Lysine Acetate U.S.P.— 105 mg (Eq. to L-Lysine 75 mg) L-Threonine U.S.P.—53 mg L-Tryptophan U.S.P—23 mg L- Histidine U.S.P.—38 mg L-Tyrosine U.S.P. —30 mg Total nitrogen content per tablet —36 mg Calcium content per tablet —1.25 mmol=0.05 g Excipients —q.s. Colour : Titanium Dioxide I.P. |
| 40 | BIOTIN WITH CALCIUM PANTOTHENATE, N-ACETYLCYSTEINE, L-METHIONINE, FOLIC ACID & MINERALS TABLETS | Each film coated tablet contains:
Biotin b.p— 10 mg Calcium Pantothenate i.p—30 mg N-acetylcysteine usp—150 mg L-Methionine usp—50 mg Folic acid i.p—400 mcg Sodium selenite usp eq. to Elemental selenium–100 mcg Cupric oxide eq. to elemental copper—3 mg Zinc sulphate monohydrate i.p eq. to zinc sulphate—20 mg Excipients–q.s Colour: Carmoisine |
| 41 | GLUTATHIONE TABLETS 1000 MG | Each film coated tablet contains:
Glutathione b.p—1000 mg Excipients–q.s Colour: Titanium dioxide i.p |
| 42 | VITAMIN C, SODIUM ASCORBATE & ZINC CITRATE CHEWABLE TABLETS | Each uncoated chewable tablet contains:
Ascorbic acid i.p (Vit. C) — 100 mg Sodium ascorbate i.p—450 mg Zinc citrate eq. to elemental zinc—5mg Excipients–q.s Appropriate overages of vitamins added to compensate for loss |
| 43 | ZINC SULPHATE, COPPER SULPHATE, MANGANESE SULPHATE, SODIUM SELENATE, LYCOPENE & CHROMIUM CHLORIDE TABLETS | Each film coated tablet contains:
Zinc Sulphate Monohydrate i.p eq. to elemental zinc— 1 mg Copper Sulphate Pentahydrate b.p eq. to elemental copper– Maganese Sulphate usp eq. to elemental manganese—0.10 mg Sodium Selenate eq. to elemental selenium— 20mcg Lycopene (10%) usp— 10 mcg Chromium chloride usp eq. to elemental chromium— 4 mcg Excipients—q.s Colour: Approved Colour Used |
| 44 | MAGNESIUM OROTATE & CALCIUM PHOSPHATE DIBASIC TABLETS | Each film coated tablet contains:
Calcium phosphate dibasic ip— 136 mg Magnesium Orotate — 500 mg Excipients–q.s Colour: Approved colours used |
| 45 | ZINC ACETATE TABLETS | Each film coated tablet contains:
Zinc acetate usp (as dihydrate)—167.86 eq.to elemental zinc—-50 mg Colour: Approved colours used. |
| 46 | POTASSIUM CHLORIDE BP TABLETS | Each film coated tablet contains:
Potassium Chloride I.P—600 mg Excipients—q.s Colour: Approved colour used. |
| 47 | GLUTATHIONE TABLETS 500 MG | Each film coated tablets contains:
Glutathione BP—-500 mg Excipoients—q.s Colour: Approved colour used. |
| 48 | COLOSTRUM, VITAMIN C, VITAMIN D3, ZINC & SELENIUM TABLETS | Each film coated tablet contains:
Colostrum—250 mg Ascorbic Acid I.P—500 mg Vitamin D3 I.P—2000 I.U Zinc Silphate Monohydrate I.P eq. to elemental zinc—35 mg Sodium Selenite U.S.P eq. to elemental selenium—40 mcg Excipiets:—q.s Colour: Titanium Dioxide I.P Appropriate overages of vitamins added to compensate for loss |
| 49 | CORAL CALCIUM, METHYLCOBALAMIN, FOLIC ACID & PYRIDOXINE HCL TABLETS | Each film coated tablet contains:
Coral calcium eq. to elemental calcium—225 mg Methylcobalamin I.P—1500 mg Folic Acid I.P—1.5 mg Pyridoxine hcl i.p—3 mg Excipients—q.s colour: Approved colour used. |
| 50 | L-CARNITINE L-TARTRATE, MECOBALAMIN & FOLIC ACID TABLETS | Each film coated tablet contains:
L-Carnitine L-tartrate eq. to L-Carnitine—500 mg Mecobalamin I.P—1500 mcg Folic Acid I.P—1.5 mg Excipients—q.s colour: Approved colour used. |
| 51 | THIAMINE HCL, RIBOFLAVIN, PYRIDOXINE HCL | Each film caoted tablet contains:
Thiamine Hydrochloride IP—250 mg Riboflavin (as sodium phosphate) IP—4 mg Pyridoxine Hydrochloride IP—50 mg Excipients—q.s Colour: Approved colour used. |
| 52 | ADEMETIONINE TABLETS | Each enteric coated tablet contains:
Ademetionine 1-4 butane disulfonate (sd4) eq. to Ademetionine Ion—400 mg Excipients—q.s Colour: Approved colour used. |
| 53 | THIAMINE NITRATE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID AND MINERALS | Each film coated tablet contains:
Thiamine Nitrate IP—300 mg Pyridoxine Hydrochloride IP—50 mg Folic Acid IP—1.5 mg Zinc Sulphate Monohydrate IP eq. to Elemental Zinc—50 mg Magnesium Citrate BP—375 mg Selenium Dioxide eq. to Elemental Selenium USP—200 mcg Cupric Oxide eq. to Elemental Copper—2 mg Excipients—q.s Colour: Approved colour used. |
| 54 | L-CARNITINE, UBIDECARENONE (CO-ENZYME Q10), VITAMIN E,METHYLCOBALAMIN & FOLIC ACID TABLETS | Each film coated tablet contains:
L-Carnitine—500 mg Ubidecarenone (co-enzyme q10)—100 mg Vitamin E—400 mg Methylcobalamin I.P—1500 mcg Folic Acid I.P—1.5 mg Excipients—q.s Colour: Approved colour used. Appropriate overages of vitamins are added to compensate any |
| 55 | ADEMETHIONINE TABLETS 400 MG | Each enteric coated tablet contains:
Ademetionine 1-4 butane disulfonate (sd4) eq. to Ademetionine Ion—400 mg Excipients—q.s Colour: Approved colour used. |
| 56 | LEVOCARNITINE TABLETS U.S.P. | Each film coated tablets contains:
Levocarnitine U.S.P.—500 mg Excipients—q.s Colour: Approved colour used. |
| 57 | LEVOCARNITINE TABLETS U.S.P. | Each film coated tablets contains:
Levocarnitine U.S.P.—330 mg Excipients—q.s Colour: Approved colour used. |
| ANTIMEASMA | ||
| S. No. | Generic Name | Composition |
| 1 | TRANEXAMIC ACID & GLUTATHIONE TABLETS | Each film coated tablet contains:
Tranexamic acid i.p—250 mg Glutathione—50 mg Excipients–q.s Colour: Titanium dioxide i.p |
| 2 | TRANEXAMIC ACID TABLETS IP 250 MG | Each film coated tablet contains:
Tranexamic Acid I.P—250 mg Excipients–q.s Colour: Approved colour used |
| 3 | TRANEXAMIC ACID TABLETS IP 500 MG | Each film coated tablet contains:
Tranexamic Acid I.P—500 mg Excipients–q.s Colour: Approved colour used |
| 4 | TRANEXAMIC ACID TABLETS IP | Each film coated tablet contains:
Tranexamic Acid IP—500 mg Excipients—q.s Colour: Approved colour used. |
| 5 | ETAMSYLATE TABLETS 250 MG | Each uncoated tablet contains:
Etamsylate b.p–250 mg Excipients–q.s |
| 6 | ETAMSYLATE TABLETS 500 MG | Each uncoated tablet contains:
Etamsylate b.p–500 mg Excipients–q.s |
| 7 | ETAMSYLATE TABLET | Each film coated tablet contains:
Etamsylate B.P—500 mg Excipients—q.s |
| 8 | ETAMSYLATE TABLETS 500 MG | Each uncoated tablet contains:
Etamsylate B.P—500 mg Excipients—q.s |
| OSTEOARTHERITIS | ||
| S. No. | Generic Name | Composition |
| 1 | GLUCOSAMINE, METHYLSULFONYLMETHANE & DIACEREIN TABLETS | Each film coated tablet contains:
Glucosamine sulfate Potassium chloride usp—750 mg Methylsulfonylmethane usp—250 mg Diacerine i.p—50 mg Excipients–q.s Colour: Ferric oxide yellow usp-nf & titanium dioxide i.p |
| 2 | GLUCOSAMINE TABLETS USP | Each film coated tablet contains:
Glucosamine Sulfate Potassium Chloride—1500 mg Excipients—q.s Colour: Approved colour used. |
| 3 | GLUCOSAMINE TABLETS USP | Each film coated tablet contains:
Glucosamine Sulfate Potassium Chloride USP—844.9 mg eq. to Glucosamine—500 mg Excipients—q.s Colour: Approved colour used. |
| 4 | GLUCOSAMINE AND DIACEREIN TABLETS | Each film coated tablet contains:
Glucosamine Sulphate Potassium Chloride USP—500 mg Diacerein IP—50 mg Excipients—q.s Colour: Approved colour used. |
| ANTIGOUT | ||
| S. No. | Generic Name | Composition |
| 1 | COLCHICINE TABLETS B.P 0.5 MG | Each uncoated tablet contains:
Colchicine B.P—0.5 mg Exccipients—q.s |
| 2 | COLCHICINE TABLETS B.P 0.5 MG | Each uncoated tablet contains:
Colchicine B.P—0.5 mg Exccipients—q.s |
| 3 | COLCHICINE TABLETS B.P 0.5 MG | Each uncoated tablet contains:
Colchicine B.P—0.5 mg Exccipients—q.s |
| 4 | COLCHICINE TABLETS BP 0.5 MG | Each uncoated tablet contains:
Colchicine B.P—0.5 mg Excipients—q.s |
| ANTIPLATELETS | ||
| S. No. | Generic Name | Composition |
| 1 | ASPIRIN & CLOPIDOGREL TABLETS (75 MG + 75 MG) | Each film coated tablet contains:
Aspirin i.p—75 mg Clopidogrel Bisulphate i.p eq. to Clopidogrel—75 mg Excipients–q.s Colour: Ferric oxide red usp-nf & titanium dioxide ip |
| 2 | CLOPIDOGREL & ASPIRIN TABLETS
| Each film coated tablet contains:
Clopidogrel Bisulphate USP eq. to Clopidogrel—75 mg Aspirin USP—75 mg Colour: Approved colour used |
| 3 | ASPIRIN & CLOPIDOGREL TABLETS (75 MG + 75 MG) | Each film coated tablet contains:
Aspirin i.p—75 mg Clopidogrel Bisulphate i.p eq. to Clopidogrel—75 mg Excipients–q.s Colour: Approved colour used. |
| 4 | TICAGRELOR TABLET 90 MG | Each film coated tablet contains:
Ticagrelor IP—90 mg Excipients—q.s colour: Approved colour used. |
| ANTI-HYPERPHOSPHATEMIA | ||
| S. No. | Generic Name | Composition |
| 1 | SEVELAMER CARBONATE TABLETS 400 MG | Each film coated tablet contains:
Sevelamer carbonate—400 mg Excipients–q.s Colour: Titanium Dioxide i.p |
| 2 | SEVELAMER CARBONATE TABLETS 800 MG | Each film coated tablet contains:
Sevelamer carbonate—800 mg Excipients–q.s Colour: Titanium Dioxide i.p |
| 3 | SEVELAMAR CARBONATE TABLETS 800 MG | Each film coated tablet contains:
Sevelamer carbonate—800 mg Excipients–q.s Colour: Approved colour used |
| 4 | SEVELAMAR CARBONATE TABLETS 400 MG | Each film coated tablets contains:
Sevelamar Carbonate—400 mg Excipients—q.s Colour: Approved colour used. |
| CALCIMIMETICS | ||
| S. No. | Generic Name | Composition |
| 1 | CINACALCET TABLET 60 MG | Each film coated tablet contains:
Cinacalcet Hydrochloride i.p eq. to cinacalcet–60 mg Excipients–q.s Colour: Quinoline yellow & titanium dioxide i.p |
| 2 | CINACALCET TABLET 90 MG | Each film coated tablet contains:
Cinacalcet Hydrochloride i.p eq. to cinacalcet–90 mg Excipients–q.s Colour: Titanium dioxide i.p |
| 3 | CINACALCET TABLET 30 MG | Each film coated tablet contains:
Cinacalcet Hydrochloride i.p eq. to cinacalcet–30 mg Excipients–q.s Colour: Ferric oxide yellow usp-nf lake of indigo ,& |
| ANTINEOPLASTIC KINASE INHIBITOR | ||
| S. No. | Generic Name | Composition |
| 1 | NILOTINIB TABLETS 200 MG | Each film coated tablet contains:
Nilotinib—200 mg Excipients—q.s Colour: Approved colour used. |
| 2 | NILOTINIB TABLETS 200 MG | Each film coated tablet contains:
Nilotinib—200 mg Excipients—q.s Colour: Approved colour used. |
| 3 | PAZOPANIB TABLETS 200 MG | Each film coated tablet contains:
Pazopanib Hydrochloride eq. to Pazopanib—200 mg Excipients—q.s Colour: Approved colour used. |
| 4 | PAZOPANIB TABLETS 400 MG | Each film coated tablet contains:
Pazopanib Hydrochloride eq. to Pazopanib—400 mg Excipients—q.s Colour: Approved colour used. |
| 5 | METHOTREXATE TABLETS IP 5 MG | Each uncoated tablet contains:
Methotrexate IP—5 mg Excipients—q.s |
| COPD | ||
| S. No. | Generic Name | Composition |
| 1 | N-ACETYLCYSTEINE & ACEBROPHYLLINE TABLETS | Each film coated bi-layered tablet contains:
N-Acetylcysteine usp—600 mg Acebrophylline—100 mg Excipients–q.s Colour: Lake of quinoline yellow & Titanium dioxide i.p |
| 2 | N-ACETYLCYSTEINE TABLETS 600 MG | Each film coated tablet contains:
N-Acetylcysteine usp—600 mg Excipients–q.s Colour: Titanium dioxide i.p |
| 3 | MONTELUKAST & ACEBROPHYLLINE
| Each film caoted bilayered tablet contains:
Montelukast Sodium IP eq. to Montelukast—10 mg (in immediate release form) Acebrophylline—200 mg (in sustained release form) Colour: Approved colour used |
| 4 | ACEBROPHYLLINE SR TABLETS | Each uncoated sustained release tablets contains:
Acebrophylline—200 mg Excipients—q.s |
| DIURETICS | ||
| S. No. | Generic Name | Composition |
| 1 | TORSEMIDE TABLET I.P 20 MG | Each uncaoted tablet contains:
Torsemide i.p—20 mg Excipients–q.s |
| 2 | TORSEMIDE TABLET I.P 40 MG | Each uncaoted tablet contains:
Torsemide i.p—40 mg Excipients–q.s |
| 3 | TORSEMIDE TABLET I.P 100 MG | Each uncaoted tablet contains:
Torsemide i.p—100 mg Excipients–q.s |
| 4 | TORSEMIDE TABLETS I.P 10 MG | Each uncaoted tablet contains:
Torsemide i.p—10 mg Excipients–q.s |
| 5 | TOLVAPTAN TABLETS 15 MG | Each uncoated tablet contains:
Tolvaptan i.p—15 mg Excipients–q.s Colour: Birilliant blue fcf |
| 6 | TOLVAPTAN TABLETS 30 MG | Each uncoated tablet contains:
Tolvaptan i.p—30 mg Excipients–q.s Colour: Birilliant blue fcf |
| 7 | TORSEMIDE & SPIRONOLACTONE TABLETS (10MG+50MG) | Each film coated tablet contains:
Torsemide usp— 10 mg Spirnolactone i.p— 50 mg Excipients–q.s Approved colours used |
| 8 | TORSEMIDE & SPIRONOLACTONE TABLETS (20MG+50MG) | Each film coated tablet contains:
Torsemide usp— 20 mg Spirnolactone i.p— 50 mg Excipients–q.s Approved colours used |
| 9 | TORSEMIDE & SPIRONOLACTONE TABLETS (10 MG+50 MG) | Each film caoted tablet contains:
Torsemide USP—10 mg Spironolactone I.P—50 mg Excipients–q.s Approved colour used. |
| 10 | TORSEMIDE & SPIRONOLACTONE TABLETS (20 MG+50 MG) | Each film caoted tablet contains:
Torsemide USP—20 mg Spironolactone I.P—50 mg Excipients–q.s Approved colour used. |
| 11 | TORSEMIDE & SPIRONOLACTONE TABLETS IP | Each uncoated tablets contains:
Torsemide I.P—20 mg Spironolactone I.P—50 mg Excipients—q.s |
| 12 | TORSEMIDE & SPIRONOLACTONE TABLET I.P | Each uncoated tablet contains:
Torsemide I.P—5 mg Spironolactone I.P—50 mg Excipients—q.s |
| 13 | TORSEMIDE & SPIRONOLACTONE TABLET I.P | Each uncoated tablet contains:
Torsemide I.P—10 mg Spironolactone I.P—50 mg Excipients—q.s |
| 14 | SPIRONOLACTONE TABLETS I.P 50 MG | Each uncoated tablet contains:
Spironolactone I.P—50 mg Excipients—q.s |
| 15 | TORSEMIDE TABLETS I.P 5 MG | Each uncoated tablet contains:
Torsemide I.P—5 mg Excipienst—q.s |
| 16 | TORSEMIDE TABLETS I.P 80 MG | Each uncoated tablet contains:
Torsemide I.P—80 mg Excipienst—q.s |
| 17 | TOLVAPTAN TABLETS 15 MG | Each uncoated tablet contains:
Tolvaptan IP—15 mg Excipients—q.s Colour: Brilliant Blue Fcf |
| ANTIMALERIAL | ||
| S. No. | Generic Name | Composition |
| 1 | ARTEMETHER 80 MG & LUMEFANTRINE 480 MG TABLETS | Each film coated tablet contains:
Artemether i.p—80 mg Lumefantrine—480 mg Excipient—q.s Colour: Approved colour used. |
| PEPTIDE & SUPPLEMENT | ||
| S. No. | Generic Name | Composition |
| 1 | L-GLUTATHIONE TABLET | Each film coated tablets contains: L-Glutathione—600 mg Excipients—q.s Colour: Approved colour used. |
| 2 | L-GLUTATHIONE & VITAMIN C TABLET | Each film coated tablets contains: L-Glutathione—500 mg Vitamin C—500 mg Excipients—q.s Colour: Approved colour used. |
| 3 | L-GLUTATHIONE TABLETS | Each film coated tablet contains: L-Glutathione—500 mg Excipients—q.s Colour: Approved colour used. |
| ANTIOXIDANT | ||
| S. No. | Generic Name | Composition |
| 1 | N-ACETYLCYSTEINE & TAURINE TABLETS (150 mg+ 500 mg) | Each film coated tablet contains: N-Acetylcysteine u.s.p.—150 mg Taurine u.s.p.—500 mg Excipients–q.s Colour: Sunset Yellow |
| 2 | N-ACETYLCYSTEINE & TAURINE TABLETS (300 mg+ 500 mg) | Each film coated tablet contains: N-Acetylcysteine u.s.p.—300 mg Taurine u.s.p.—500 mg Excipients–q.s Colour: Ferric oxide red usp-nf & titanium dioxide i.p |
| ANTISPASMODIC | ||
| S. No. | Generic Name | Composition |
| 1 | DROTAVERINE HYDROCHLORIDE TABLETS I.P 80 MG | Each film coated tablet contains: Drotaverine Hydrochloride i.p—80 mg Excipients–q.s Colour: Ferric oxide yellow usp-nf & titanium dioxide i.p |
| 2 | DROTAVERINE HYDROCHLORIDE & MEFENAMIC ACID TABLET | Each film coated tablet contains: Drotaverine Hydrochloride i.p—80 mg Mefenamic acid i.p—250 mg Excipients–q.s Colour: Erthrosine & titanium dioxide i.p |
| 3 | MEBEVERINE HYDROCHLORIDE TABLETS I.P 135 MG | Each filmcoated tablet contains: Mebeverine hydrochloride i.p—135 mg Excipients–q.s Coloure: Approved colours used |
| 4 | DICYCLOMINE HYDROCHLORIDE & MEFENAMIC TABLETS I.P | Each uncoated tablet contains: Mefenamic acid i.p—250 mg Dicyclomine hydrochloride i.p—10 mg Excipients–q.s Colour: Approved colour used. |
| 5 | MEFENAMIC ACID & DICYCLOMINE HYDROCHLORIDE TABLETS IP | Each uncaoted tablet contains: Mefenamic Acid I.P—250 mg Dicyclomine Hydrochloride I.P—20 mg Excipients—q.s Colour: Approved colour used. |
| KINASE INHIBITOR | ||
| S. No. | Generic Name | Composition |
| 1 | EVEROLIMUS TABLETS 2.5 MG | Each film coated tablet contains: Everolimus— 2.5 mg Excipients—q.s Approved colours used |
| 2 | EVEROLIMUS TABLETS 5 MG | Each film coated tablet contains: Everolimus—5 mg Excipients—q.s Approved colours used |
| 3 | EVEROLIMUS TABLETS 10 MG | Each film coated tablet contains: Everolimus— 10 mg Excipients—q.s Approved colours used |
| 4 | EVEROLIMUS TABLETS 5 MG | Each uncoated tablet contains: Everolimus—5 mg Excipients—q.s |
| 5 | EVEROLIMUS TABLETS 5 MG | Each film coated tablet contains: Everolimus—5 mg Excipients—q.s Approved colours used |
| DIABETIC NEUROPATY & NEUROPATHIC PAIN | ||
| S. No. | Generic Name | Composition |
| 1 | METHYLCOBALAMIN & GABAPENTIN TABLETS | Each film coated tablet contains: Methylcobalamin i.p– 500 mcg Gabapentin i.p— 100 mg Excipients– q.s Colour: Approved colour used |
| 2 | PREGABALIN PROLONGED RELEASE & ETORICOXIB TABLETS | Each uncoted bilayer tablets contains: Pregabalin I.P—75 mg (as prolonged release) Etoricoxib I.P—60 mg Excipients—q.s Colour: Approved colour used. |
| 3 | METHYLCOBALAMIN & PREGABALIN TABLETS | Each film coated tablet contains: Methylcobalamin I.P—500 mg Pregabalin I.P—50 mg Excipients—q.s Colour: Approved colour used |
| 4 | GABAPENTIN & METHYLCOBALAMIN TABLETS | Each film coated tablet contains: Gabapentin USP—300 mg Methylcobalamin—750 mcg Excipients—q.s Colour: Approved colour usedd. |
| 5 | GABAPENTIN & METHYLCOBALAMIN TABLETS & NORTRIPTYLINE TABLETS | Each film coated tablets contains: Gabapentin IP—400 mg Methylcobalamin IP—500 mcg Nortriptyline Hyddrochloride IP eq. to Nortriptyline—10 mg Excipients—q.s Colour: Approved colour used |
| 6 | Epalrestat Sustained Release Tablets 50 mg | Each film coated tablet contains: Epalrestat—50 mg Excipients—q.s Colour: Approved colour used. |
| 7 | METHYLCOBALAMIN & GABAPENTIN TABLETS | Each film coated tablet contains: Methylcobalamin I.P—500 mcg Gabapentin I.P—100 mg Excipients—q.s Colour: Approved colour used. |
| 8 | PREGABALIN & NORTRIPTYLINE TABLETS | Each film coated tablet contains: Pregabalin IP—50 mg Nortriptyline Hydrochloride IP eq. to Nortriptyline—10 mg Excipients—q.s Colour: Approved colour used. |
| PHOSPHODIAESTERASE INHIBITOR | ||
| S. No. | Generic Name | Composition |
| 1 | APREMILAST TABLETS 10 MG | Each film coated tablet contains: Apremilast—10 mg Excipients—q.s Colour: Approved colour used. |
| 2 | APREMILAST TABLETS 30 MG | Each film coated tablet contains: Apremilast—30 mg Excipients—q.s Colour: Approved colour used. |
| STEROIDS | ||
| S. No. | Generic Name | Composition |
| 1 | DEXAMETHASONE TABLETS I.P | Each uncoated tablets contains: Dexamethasone I.P—4 mg Excipients—q.s |
| 2 | DEXAMETHASONE TABLETS I.P 0.5 MG | Each uncoated tablet contains: Dexamethasone IP—0.5 mg Excipients—q.s |
| 3 | DEXAMETHASONE TABLETS IP | Each uncoated tablet contains: Dexamethasone IP—0.5 mg Excipients—q.s |
| XANTHINE OXIDASE INHIBITOR | ||
| S. No. | Generic Name | Composition |
| 1 | FEBUXOSTAT EXTENDED-RELEASE TABLETS 40 MG | Each film coated extended-release tablt contains: Febuxostat—40 mg Excipients–q.s Cololur: Ferric oxide red usp-nf & titanium dioxide i.p |
| 2 | RIVAROXABAN TABLETS 10 MG | Each film coated tablet contains: Rivaroxaban—10mg Excipients—q.s Colour: Approved colour used |
| 3 | FEBUXOSTATE TABLETS 80 MG | Each film coated extended-release tablt contains: Febuxostat—80 mg Excipients–q.s Cololur: Approved colour used. |
| 4 | FEBUXOSTATE TABLETS 40 MG | Each film coated extended-release tablt contains: Febuxostat—40 mg Excipients–q.s Cololur: Approved colour used. |
| IRON CHELATORS | ||
| S. No. | Generic Name | Composition |
| 1 | DEFERASIROX TABLETS (180 mg) | Each film coated tablet contains: Deferasirox—180 mg Excipients—q.s Colour: Approved colour used. |
| 2 | DEFERASIROX TABLETS (90 mg) | Each film coated tablet contains: Deferasirox—90 mg Excipients—q.s Colour: Approved colour used. |
| 3 | DEFERASIROX TABLETS (180 mg) | Each film coated tablet contains: Deferasirox—180 mg Excipients—q.s Colour: Approved colour used. |
| 4 | DEFERASIROX TABLETS (90 mg) | Each film coated tablet contains: Deferasirox—90 mg Excipients—q.s Colour: Approved colour used. |
| 5 | DEFERASIROX DISPERSIBLE TABLETS | Each uncoated dispersible tablets contains: Deferasirox—500 mg Excipinets—q.s |
| 6 | DEFERASIROX DISPERSIBLE TABLETS | Each uncoated dispersible tablets contains: Deferasirox—500 mg Excipinets—q.s |
| ELECTROLYTE SUPPLEMENT | ||
| S. No. | Generic Name | Composition |
| 1 | PROLONGED-RELEASE POTASSIUM CHLORIDE TABLETS B.P 750 MG | Each film coated prolonged-release tablet contains: Potassium chloride i.p—750mg Excipients–q.s Colour: Titanium dioxide i.p |
| 2 | ALPHA KETOANALOGUE TABLETS | Each film coated tablet contains : Calcium -3-methyl-2-oxo-valerate —134 mg (α-ketoanalogue to isoleucine, Calcium salt) Calcium-4-methyl-2-oxo-valerate—202 mg (α-ketoanalogue to leucine, Calcium salt) Calcium-2-oxo-3-phenylpropionate—136 mg (α-ketoanalogue to phenylalanine, Calcium salt) Calcium -3-methyl-2-oxo-butyrate— 172 mg (α-ketoanalogue to valine, Calcium salt) Calcium –Dl-2-Hydroxy -4(Methylthio) Butyrate—118 mg (α-hydroxyanalogue to methionine, Calcium salt) L-Lysine Acetate U.S.P.— 210 mg (Eq. to L-Lysine 150 mg) L-Threonine U.S.P.—106 mg L-Tryptophan U.S.P—46 mg L- Histidine U.S.P.—76 mg L-Tyrosine U.S.P. —60 mg Total nitrogen content per tablet —72 mg Calcium content per tablet —2.5 mmol=0.10 g Excipients —q.s. Colour : Approved colour used Appropriate overages added to compensate for loss on storages |
| 3 | SODIUM CHLORIDE TABLETS USP 1 GM | Each film coated tablet contains: Sodium Chloride i.p— 1gm Excipients—q.s Approved colour used. |
| MUSCLE RELAXANT | ||
| S. No. | Generic Name | Composition |
| 1 | MIRABEGRON EXTENDED RELEASE TABLET 50 MG | Each film coated extended release tablet contains: Mirabegron—50 mg Excipients—q.s Colour: Approved colour used. |
| 2 | MIRABEGRON EXTENDED RELEASE TABLET 25 MG | Each film coated extended release tablet contains: Mirabegron—25 mg Excipients—q.s Colour: Approved colour used. |
| 3 | TAMSULOSIN HYDROCHLORIDE | Each film coated tablet contains: Tamsulosin Hydrochloride IP—0.4 mg (as extended release ) Dutasteride IP—0.5 mg Colour: Approved colour used |
| 4 | TAMSULOSIN HYDROCHLORIDE & FINASTERIDE TABLETS | Each film coated tablet contains: Tamsulosin Hydrochloride IP—0.4 mg (as sustained release ) Finasteride IP—5 mg Excipients—q.s Colour: Approved colour used |
| 5 | TOLPERISONE HYDROCHLORIDE TABLETS | Each film coated tablet contains: Tolperisone Hydrochloride JP—150 mg Excipients—q.s Colour: Approved colour used. |
| 6 | TOLPERISONE HYDROCHLORIDE & ETODOLAC TABLETS | Each film coated tablet contains: Tolperisone Hydrochloride JP—150 mg Etodolac IP—400 mg Excipients—q.s Colour: Approved colour used. |
| 7 | TOLPERSIONE HYDROCHLORIDE TABLETS 150 MG | Each film coated tablet contains: Tolpersione Hydrochloride JP—150 mg Excipients–q.s Colour: Approved colour used. |
| DIGESTIVE ENZYME | ||
| S. No. | Generic Name | Composition |
| 1 | PANCREATIN TABLETS USP | Each enteric coated tablet contains: Pancreatin—150 mg Parotease—37500 USP U /Tablet Amylase—33200 USP U / Tablet Lipase—10000 USP U / Tablet Excipients—q.s Approved colour used in tablet Appropriate colour used in tablet Appropriate overages of enzymes are added to compensate the |
| 2 | PANCREATIN TABLETS USP | Each enteric coated tablet contains: Pancreatin—300 mg Parotease—62500 USP U /Tablet Amylase—74700 USP U / Tablet Lipase—25000 USP U / Tablet Excipients—q.s Approved colour used in tablet Appropriate colour used in tablet Appropriate overages of enzymes are added to compensate the |
| 3 | PAPAIN,FUNGAL DIASTASE & SIMETHICONE | Each effervescent tablet contains: Papain IP—60 mg Fungal Diastase IP (1:2000)—20 mg Simethicone IP—25 mg Excipients—q.s Colour: Sunset Yellow |
| 4 | PAPAIN,FUNGAL DIASTASE & SIMETHICONE EFFERVESCENT TABLETS | Each effervescent tablet contains: Papain IP—60 mg Fungal Diastase IP (1:2000)—20 mg Simethicone IP—25 mg Excipients—q.s Colour: Approved colour used |
| ANTIMUSCARINICS | ||
| S. No. | Generic Name | Composition |
| 1 | Solifenacin Succinate Tablets 5 mg | Each film coated tablet contains: Solifenacin Succinate B.P—5 mg Excipients—q.s Colour: Approved colour used. |
| ANTIRHEUMATIC | ||
| S. No. | Generic Name | Composition |
| 1 | LEFLUNOMIDE IP 10 MG TABLETS | Each film coated tablet contains: Leflunomide IP—10 mg Excipients—q.s Colour: Approved colour used. |
| ANDROGEN BIOSYNHESIS INHIBITOR | ||
| S. No. | Generic Name | Composition |
| 1 | ABIRATERONE ACETATE TABLETS I.P 250 MG | Each uncoated tablet contains: Abiraterone Acetate IP—250 mg Excipients—q.s |
| PROSTAT TREATMENT | ||
| S. No. | Generic Name | Composition |
| 1 | FINASTERIDE TABLETS I.P 1 MG | Each film coated tablet contains:
Finasteride IP—1 mg Excipients—q.s Colour: Approved colour used. |
.jpg){kind=link}
.jpg){kind=link}
